https://curecurrent.com/trials/to-evaluate-safety-and-tolerability-after-multiple-oral-doses-of-azd1656-in-type-2-diabetes-patients-on-top-of-metformin-8001https://curecurrent.com/trials/safety-and-pharmacokinetics-pk-of-hokt3g1-ala-ala-in-type-1-diabetes-mellitus-t1dm-8002https://curecurrent.com/trials/islet-transplantation-for-patients-with-type-1-diabetes-8003https://curecurrent.com/trials/use-of-midlevel-providers-in-diabetes-management-8004https://curecurrent.com/trials/a-pilot-study-of-diabetes-risk-reduction-program-with-wic-mothers-the-special-supplemental-nutrition-program-for-women-i-8005https://curecurrent.com/trials/evaluation-of-diabetes-self-management-consultant-care-8006https://curecurrent.com/trials/treatment-of-diabetic-nephropathy-8007https://curecurrent.com/trials/new-day-nutrition-exercise-weight-loss-diabetes-and-you-8008https://curecurrent.com/trials/evaluating-health-at-every-size-haes-as-an-alternative-obesity-treatment-model-8009https://curecurrent.com/trials/community-diabetes-education-program-evaluation-code-evaluation-8010https://curecurrent.com/trials/a-study-of-the-rules-for-insulin-dosing-in-patients-using-multiple-daily-injections-8011https://curecurrent.com/trials/evaluating-tools-for-health-promotion-and-disease-prevention-8012https://curecurrent.com/trials/remote-monitoring-in-diabetes-disease-management-8013https://curecurrent.com/trials/calerie-pbrc-baton-rouge-comprehensive-assessment-of-long-term-effects-of-reducing-intake-of-energy-8014https://curecurrent.com/trials/tart-troglitazone-atherosclerosis-regression-trial-8015https://curecurrent.com/trials/effect-of-thiazolidinedione-treatment-vascular-risk-markers-8016https://curecurrent.com/trials/stepping-up-to-health-feedback-to-promote-physical-activity-in-diabetes-8017https://curecurrent.com/trials/implantable-antenna-sensors-for-continuous-glucose-monitoring-8018https://curecurrent.com/trials/evaluation-of-soluble-epoxide-hydrolase-s-eh-inhibitor-in-patients-with-mild-to-moderate-hypertension-and-impaired-gluco-8019https://curecurrent.com/trials/efficacy-and-safety-of-frequently-modified-intensive-insulin-8020https://curecurrent.com/trials/comparison-of-two-basal-insulins-for-patients-with-type-2-diabetes-iooy-8021https://curecurrent.com/trials/pirfenidone-a-new-drug-to-treat-kidney-disease-in-patients-with-diabetes-8022https://curecurrent.com/trials/to-evaluate-the-bioavailability-of-a-tablet-of-azd1656-8023https://curecurrent.com/trials/a-safety-and-efficacy-study-of-vitreosolve-for-non-proliferative-diabetic-retinopathy-subjects-8024https://curecurrent.com/trials/the-study-of-hiv-protease-inhibitors-and-their-effects-on-glucose-metabolism-8025https://curecurrent.com/trials/the-medication-adherence-program-8026https://curecurrent.com/trials/can-tailored-patient-letters-improve-the-quality-of-diabetic-patient-care-8027https://curecurrent.com/trials/improving-compliance-with-metformin-8028https://curecurrent.com/trials/mitiglinide-in-combination-with-metformin-vs-metformin-alone-in-patients-with-type-2-diabetes-mellitus-8029https://curecurrent.com/trials/study-to-assess-the-absorption-distribution-metabolism-and-excretion-of-azd1656-in-type-2-diabetes-mellitus-t2dm-8030https://curecurrent.com/trials/omentectomy-for-the-treatment-of-diabetes-mellitus-type-2-8031https://curecurrent.com/trials/effect-of-gastric-bypass-on-patients-with-type-2-diabetes-and-or-dyslipidemia-8032https://curecurrent.com/trials/effects-of-exenatide-on-postprandial-hyperlipidemia-and-inflammation-8033https://curecurrent.com/trials/insulin-therapy-in-the-hospital-comparing-two-protocols-8034https://curecurrent.com/trials/a-clinical-trial-comparing-efficacy-and-safety-of-exubera-and-humalog-8035https://curecurrent.com/trials/pilot-study-for-the-evaluation-of-intravitreal-infliximab-in-the-treatment-of-diabetic-macular-edema-8036https://curecurrent.com/trials/body-composition-assessment-in-spinal-cord-injury-8037https://curecurrent.com/trials/the-aim-is-to-estimate-the-total-amount-of-insulin-producing-cells-in-the-pancreas-by-mri-8038https://curecurrent.com/trials/reduce-obesity-and-diabetes-8039https://curecurrent.com/trials/analysis-of-the-nustep-as-an-introductory-fitness-regimen-8040https://curecurrent.com/trials/the-acute-effects-of-coffee-on-glucose-metabolism-8041https://curecurrent.com/trials/multiple-dose-escalation-trial-of-pf-04603629-given-to-subjects-with-type-2-diabetes-mellitus-8042https://curecurrent.com/trials/single-dose-study-of-pf-04603629-in-type-2-diabetic-subjects-8043https://curecurrent.com/trials/a-study-of-the-effects-of-6r-bh4-on-blood-pressure-in-subjects-with-poorly-controlled-systemic-hypertension-8044https://curecurrent.com/trials/dha-supplements-to-improve-insulin-sensitivity-in-obese-pregnant-women-the-omega-3-pregnancy-study-8045https://curecurrent.com/trials/clamp-study-comparing-inhalation-of-technosphere-insulin-in-smokers-and-non-smokers-with-type-2-diabetes-8046https://curecurrent.com/trials/effect-of-south-beach-diet-sbd-using-sbd-products-compared-to-the-american-diabetic-association-ada-diabetes-meal-plan-o-8047https://curecurrent.com/trials/resistant-starch-on-glucose-and-insulin-sensitivity-in-individuals-with-type-2-diabetes-8048https://curecurrent.com/trials/diet-exercise-and-breastfeeding-intervention-program-for-women-with-gestational-diabetes-debi-trial-8049https://curecurrent.com/trials/improving-diabetes-outcomes-a-couples-intervention-8050https://curecurrent.com/trials/clinical-evaluation-of-the-accuracy-of-the-freestyle-navigator-continuous-glucose-monitoring-system-8051https://curecurrent.com/trials/effect-of-care-management-on-diabetes-outcomes-8052https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-phx1149t-in-subjects-with-type-2-diabetes-mellitus-8053https://curecurrent.com/trials/insulin-glargine-plus-insulin-glulisine-multiple-daily-injections-mdi-versus-premix-insulin-treatment-in-subjects-with-d-8054https://curecurrent.com/trials/hyperspectral-imaging-to-assess-and-predict-diabetic-foot-ulcers-8055https://curecurrent.com/trials/the-impact-of-exercise-counseling-on-exercise-behavior-in-people-with-type-2-diabetes-a-randomized-clinical-trial-8056https://curecurrent.com/trials/pet-ct-scan-method-to-monitor-pancreatic-b-cell-loss-in-diabetes-mellitus-8057https://curecurrent.com/trials/pharmacist-assisted-medication-program-enhancing-the-regulation-of-diabetes-8058https://curecurrent.com/trials/effect-of-immediate-hemoglobin-a1c-on-glycemic-control-in-children-with-type-i-diabetes-mellitus-8059https://curecurrent.com/trials/clarksdale-diabetes-and-metabolism-clinic-chec-study-8060https://curecurrent.com/trials/to-evaluate-the-response-to-glucagon-during-hypoglycemia-8061https://curecurrent.com/trials/effect-of-cp-778-875-on-hdl-c-in-subjects-with-abnormal-lipid-levels-and-type-2-diabetes-8062https://curecurrent.com/trials/to-evaluate-24-hr-glucose-after-od-vs-bd-azd1656-8063https://curecurrent.com/trials/effects-of-nutritional-products-on-blood-glucose-in-subjects-with-type-2-diabetes-8064https://curecurrent.com/trials/gallant-9-tesaglitazar-vs-placebo-in-combination-with-insulin-8065https://curecurrent.com/trials/effect-of-insulin-glargine-in-insulin-na-ve-subjects-with-type-2-diabetes-on-oral-hypoglycemic-agent-s-8066https://curecurrent.com/trials/study-evaluating-rimonabant-efficacy-in-drug-naive-diabetic-patients-8067https://curecurrent.com/trials/new-york-city-nyc-health-ehearts-pay-for-quality-pilot-8068https://curecurrent.com/trials/obese-patients-with-type-2-diabetes-8069https://curecurrent.com/trials/a-single-dose-tolerance-and-pharmacokinetic-study-in-obese-or-overweight-type-2-diabetic-volunteers-8070https://curecurrent.com/trials/an-ascending-multi-dose-tolerance-and-pharmacokinetic-study-in-obese-or-overweight-type-2-diabetic-volunteers-8071https://curecurrent.com/trials/to-evaluate-the-hormonal-response-to-low-blood-sugar-after-a-single-oral-dose-of-azd1656-suspension-8072https://curecurrent.com/trials/study-evaluating-rimonabant-efficacy-in-insulin-treated-diabetic-patients-arpeggio-8073https://curecurrent.com/trials/conversion-of-hyperglycemic-patients-being-treated-with-intravenous-insulin-infusions-to-lantus-insulin-8074https://curecurrent.com/trials/comparison-of-insulin-glargine-and-nph-human-insulin-in-progression-of-diabetic-retinopathy-in-type-2-diabetic-patients-8075https://curecurrent.com/trials/pharmacists-management-of-diabetes-8076https://curecurrent.com/trials/pharmacokinetic-study-of-vildagliptin-in-patients-with-renal-impairment-8077https://curecurrent.com/trials/improving-diabetes-care-for-african-americans-8078https://curecurrent.com/trials/safety-tolerability-immunological-and-clinical-efficacy-of-multiple-subcutaneous-doses-of-diapep277-in-latent-autoimmune-8079https://curecurrent.com/trials/study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-bms-686117-in-subjects-with-type-2-diabetes-8080https://curecurrent.com/trials/uva-islet-cell-transplantation-in-patients-with-type-i-diabetes-8081https://curecurrent.com/trials/comparison-of-two-different-diets-on-health-outcomes-8082https://curecurrent.com/trials/self-monitoring-of-blood-glucose-with-finger-tip-vs-alternate-site-sampling-effect-on-long-term-glycemic-control-8083https://curecurrent.com/trials/investigation-of-subatmospheric-pressure-dressing-on-pressure-ulcer-healing-8084https://curecurrent.com/trials/cardiac-magnetic-resonance-imaging-for-detecting-endothelial-dysfunction-8085https://curecurrent.com/trials/study-of-weight-loss-using-gastric-stimulation-in-obese-patients-with-type-2-diabetes-8086https://curecurrent.com/trials/united-states-coronary-artery-bypass-surgery-cabg-diabetes-project-uscdp-pilot-study-8087https://curecurrent.com/trials/aging-and-cellular-mechanism-for-insulin-action-after-exercise-training-8088https://curecurrent.com/trials/epidemiology-of-hearing-loss-in-diabetic-and-non-diabetic-veterans-8089https://curecurrent.com/trials/clinical-trials-of-footwear-in-patients-with-diabetes-study-arm-2-3-8090https://curecurrent.com/trials/a-prospective-study-of-endothelial-dysfunction-and-diabetic-foot-ulcer-risk-8091https://curecurrent.com/trials/low-carbohydrate-diet-compared-to-calorie-and-fat-restricted-diet-in-patients-with-obesity-and-type-ii-diabetes-8092https://curecurrent.com/trials/the-effect-of-plantar-vibration-on-the-progression-of-peripheral-neuropathy-8093https://curecurrent.com/trials/a-prospective-evaluation-of-health-services-outcomes-and-emerging-cardiovascular-disease-biomarkers-8094https://curecurrent.com/trials/safety-and-efficacy-study-of-qr-333-in-patient-s-with-symptomatic-diabetic-neuropathy-8095https://curecurrent.com/trials/octreotide-for-the-treatment-of-sulfonylurea-associated-hypoglycemia-8096https://curecurrent.com/trials/diabetic-retina-exam-rate-does-not-increase-with-phone-reminders-in-non-hmo-population-8097https://curecurrent.com/trials/pharmacy-interventions-to-improve-chronic-disease-medication-refill-8098https://curecurrent.com/trials/automated-telephone-outreach-with-speech-recognition-to-improve-diabetes-care-a-randomized-controlled-study-8099https://curecurrent.com/trials/a-phase-2b-study-of-dio-902-or-dio-902-placebo-in-addition-to-metformin-and-atorvastatin-or-atorvastatin-placebo-for-typ-8100https://curecurrent.com/trials/effect-of-januvia-on-ghrelin-and-other-gut-hormones-in-patients-with-diabetes-8101https://curecurrent.com/trials/demonstrate-exubera-works-as-well-as-avandia-when-added-to-sulfonylurea-metformin-in-controlling-glucose-8102https://curecurrent.com/trials/preventing-heart-disease-in-underserved-patients-8103https://curecurrent.com/trials/bioburden-reduction-of-diabetic-foot-ulcer-8104https://curecurrent.com/trials/effect-of-vitamin-d-deficiency-and-vitamin-d-supplementation-on-glucose-metabolism-8105https://curecurrent.com/trials/spironolactone-for-reducing-proteinuria-in-diabetic-nephropathy-8106https://curecurrent.com/trials/study-in-patients-with-type-2-diabetes-who-are-taking-metformin-and-sulfonylurea-metformin-and-insulin-or-insulin-8107https://curecurrent.com/trials/detection-of-ischemia-in-asymptomatic-diabetics-8108https://curecurrent.com/trials/outcomes-and-cost-consequences-of-using-an-internet-co-management-module-to-improve-the-quality-of-type-1-diabetes-care-8109https://curecurrent.com/trials/signaling-mechanisms-and-vascular-function-in-patients-with-diabetes-mellitus-8110https://curecurrent.com/trials/comparison-of-enteral-products-for-tube-fed-patients-with-type-2-diabetes-8111https://curecurrent.com/trials/effect-of-cinnamon-on-glucose-and-lipid-levels-in-non-insulin-dependent-type-2-diabetes-mellitus-8112https://curecurrent.com/trials/a-pilot-study-for-the-treatment-of-iris-neovascularization-with-macugen-8113https://curecurrent.com/trials/safety-and-efficacy-study-of-an-interactive-wound-dressing-kc002-for-the-treatment-of-diabetic-foot-ulcers-8114https://curecurrent.com/trials/diabetes-and-combined-lipid-therapy-regimen-diacor-study-8115https://curecurrent.com/trials/an-online-system-to-improve-diabetes-self-care-8116https://curecurrent.com/trials/prevention-of-weight-gain-in-adult-patients-with-type-2-diabetes-treated-with-pioglitazone-8117https://curecurrent.com/trials/combination-of-sulfonylureas-and-insulin-glargine-outpatient-therapy-for-unstable-diabetes-and-impending-dka-8118https://curecurrent.com/trials/impact-of-exercise-training-intensity-on-abdominal-visceral-fat-and-risk-factors-associated-with-the-metabolic-syndrome-8119https://curecurrent.com/trials/effectiveness-and-safety-study-of-the-next-generation-dexcom-seven-continuous-glucose-monitoring-system-8120https://curecurrent.com/trials/lifestyle-intervention-s-impact-on-health-care-costs-8121https://curecurrent.com/trials/comparison-of-nutritional-products-for-people-with-type-2-diabetes-8122https://curecurrent.com/trials/evaluation-of-alt-2074-in-subjects-with-type-2-diabetes-haptoglobin-type-2-2-genotype-and-coronary-artery-disease-8123https://curecurrent.com/trials/effects-on-colesevelam-hc1-welchol-on-insulin-sensitivity-in-subjects-with-type-2-diabetes-mellitus-8124https://curecurrent.com/trials/evaluate-the-role-of-adding-amaryl-to-non-insulin-dependent-diabetes-mellitus-patients-unresponsive-to-maximum-dose-metf-8125https://curecurrent.com/trials/intravitreal-infliximab-for-diabetic-macular-edema-dme-and-choroidal-neovascularization-cnv-8126https://curecurrent.com/trials/clinical-evaluation-of-the-effect-of-duodenal-jejunal-bypass-on-type-2-diabetes-8127https://curecurrent.com/trials/effect-of-resistant-starch-type-4-on-glycemia-and-insulin-sensitivity-in-young-adults-8128https://curecurrent.com/trials/open-label-safety-pharmacodynamic-study-24wk-w-dio-902-combo-w-metformin-atorvastatin-in-t2dm-patients-8129https://curecurrent.com/trials/english-diabetes-self-management-program-8130https://curecurrent.com/trials/resistant-starch-on-glycemic-response-in-older-adults-8131https://curecurrent.com/trials/bioelectric-field-imaging-near-human-skin-wounds-8132https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-nasal-insulin-on-postprandial-glycemic-control-in-type-2-diabetic-patients-8133https://curecurrent.com/trials/use-of-mucomyst-to-ameliorate-oxidant-stress-in-diabetics-with-proteinuria-8134https://curecurrent.com/trials/self-monitoring-of-blood-glucose-study-1-the-ability-of-people-with-diabetes-to-use-onetouch-r-ultrasmart-tm-8135https://curecurrent.com/trials/anti-thymocyte-globulin-cyclosporine-and-rad-in-islet-transplantation-8136https://curecurrent.com/trials/theragauze-alone-and-regranex-gel-0-01-plus-theragauze-in-the-treatment-of-wagner-stage-i-diabetic-foot-ulcers-8137https://curecurrent.com/trials/the-effects-of-natural-versus-man-made-trans-fatty-acids-on-lipoprotein-profiles-a-pilot-study-8138https://curecurrent.com/trials/pilot-study-on-the-effect-of-oral-controlled-release-alpha-lipoic-acid-on-oxidative-stress-in-adolescents-with-type-1-di-8139https://curecurrent.com/trials/efficacy-and-safety-study-in-the-treatment-of-chronic-diabetic-foot-ulcers-8140https://curecurrent.com/trials/effects-of-insulin-sensitizers-in-subjects-with-impaired-glucose-tolerance-8141https://curecurrent.com/trials/a-clinical-trial-assessing-the-impact-of-the-availability-of-inhaled-insulin-on-glucose-control-8142https://curecurrent.com/trials/a-comparison-of-primary-care-and-traditional-internal-medicine-residents-8143https://curecurrent.com/trials/tailored-messages-to-increase-eye-examination-behavior-8144https://curecurrent.com/trials/an-open-label-dose-finding-trial-of-viagra-for-the-treatment-of-neuropathic-pain-in-diabetes-mellitus-8145https://curecurrent.com/trials/motor-learning-in-gait-in-subjects-with-diabetic-peripheral-neuropathy-8146https://curecurrent.com/trials/g-plus-gallant-gallex-and-armor-post-treatment-follow-up-study-8147https://curecurrent.com/trials/gallex-1-long-term-extension-study-in-patients-with-type-2-diabetes-8148https://curecurrent.com/trials/a-prospective-randomized-parallel-crossover-study-demonstrating-subject-wearability-and-usability-of-the-i-port-injectio-8149https://curecurrent.com/trials/to-examine-the-lung-when-people-with-diabetes-take-an-inhaled-form-of-insulin-compared-to-subcutaneous-insulin-8150https://curecurrent.com/trials/genetic-influence-on-susceptibility-to-type-1-diabetes-mellitus-8151https://curecurrent.com/trials/treatment-of-tac-expressing-cutaneous-t-cell-lymphoma-ctcl-and-adult-t-cell-leukemia-atl-with-yttrium-90-radiolabeled-an-8152https://curecurrent.com/trials/endothelial-progenitor-cells-and-risk-factors-for-coronary-artery-disease-8153https://curecurrent.com/trials/hat-in-eye-complications-of-behcet-s-disease-8154https://curecurrent.com/trials/long-term-follow-up-of-patients-enrolled-in-the-early-treatment-diabetic-retinopathy-study-etdrs-8155https://curecurrent.com/trials/triamcinolone-acetonide-injections-to-treat-diabetic-macular-edema-8156https://curecurrent.com/trials/daclizumab-injections-to-treat-non-infectious-sight-threatening-uveitis-8157https://curecurrent.com/trials/diabetic-retinopathy-and-visual-function-study-8158https://curecurrent.com/trials/leptin-to-treat-severe-insulin-resistance-pilot-study-8159https://curecurrent.com/trials/laser-and-medical-treatment-of-diabetic-macular-edema-8160https://curecurrent.com/trials/health-effects-of-liposuction-in-overweight-women-with-elevated-insulin-levels-impaired-glucose-tolerance-and-or-type-2-8161https://curecurrent.com/trials/treatment-of-nonalcoholic-steatohepatitis-with-pioglitazone-8162https://curecurrent.com/trials/long-term-follow-up-of-diabetic-retinopathy-8163https://curecurrent.com/trials/leptin-to-treat-lipodystrophy-8164https://curecurrent.com/trials/study-of-the-effects-of-vitamin-c-on-patients-with-type-2-diabetes-8165https://curecurrent.com/trials/laser-and-antioxidant-treatment-of-diabetic-macular-edema-8166https://curecurrent.com/trials/potential-risk-factors-for-stroke-8167https://curecurrent.com/trials/vascular-effects-of-endothelium-derived-versus-hemoglobin-transported-nitric-oxide-in-healthy-subjects-8168https://curecurrent.com/trials/dextromethorphan-versus-placebo-for-neuropathic-pain-8169https://curecurrent.com/trials/effect-of-high-monounsaturated-fat-diet-on-glycemic-control-and-cardiovascular-risk-factors-in-type-2-diabetes-8170https://curecurrent.com/trials/a-phase-1-2a-study-of-the-2s-4r-enantiomer-of-ketoconazole-in-subjects-with-type-2-diabetes-mellitus-8171https://curecurrent.com/trials/a-clinical-trial-assessing-the-impact-of-inhaled-insulin-on-glucose-disposition-8172https://curecurrent.com/trials/study-to-estimate-the-effects-of-inhaled-versus-intravenous-iv-infusion-of-human-insulin-in-subjects-with-type-1-diabete-8173https://curecurrent.com/trials/pet-imaging-of-regional-variation-in-insulin-sensitivity-of-adipose-tissue-in-humans-8174https://curecurrent.com/trials/improving-care-for-patients-with-diabetes-and-poor-numeracy-skills-8175https://curecurrent.com/trials/evaluation-of-the-efficacy-of-cesamet-for-the-treatment-of-pain-in-patients-with-diabetic-peripheral-neuropathy-8176https://curecurrent.com/trials/effect-of-pulsing-electrical-fields-on-lower-extremity-diabetic-neuropathy-a-pilot-open-label-study-8177https://curecurrent.com/trials/to-examine-the-lung-when-people-with-diabetes-take-an-inhaled-form-of-insulin-compared-to-subcutaneous-insulin-8178https://curecurrent.com/trials/us-inhaled-insulin-dose-titration-study-8179https://curecurrent.com/trials/andes-agi-1067-as-a-novel-antidiabetic-agent-evaluation-study-8180https://curecurrent.com/trials/a-clinical-trial-comparing-short-term-efficacy-and-safety-of-exubera-and-lantus-8181https://curecurrent.com/trials/vascular-function-in-adolescent-diabetic-children-8182https://curecurrent.com/trials/assessment-of-stability-of-mail-in-capillary-hemoglobin-a1c-test-kit-8183https://curecurrent.com/trials/anti-nephropathic-effects-of-chronic-intermittent-intravenous-insulin-therapy-ciiit-8184https://curecurrent.com/trials/pilot-study-of-the-safety-and-clinical-efficacy-of-topical-dermacyn-wound-care-to-treat-mild-diabetic-foot-infections-8185https://curecurrent.com/trials/tolerability-of-three-local-anesthetic-formulations-in-conjunction-with-ngx-4010-for-the-treatment-of-neuropathic-pain-8186https://curecurrent.com/trials/long-term-study-of-safety-and-efficacy-of-welchol-as-an-additional-therapy-in-patients-with-type-2-diabetes-8187https://curecurrent.com/trials/patients-with-renal-impairment-and-diabetes-undergoing-computed-tomography-ct-8188https://curecurrent.com/trials/safety-and-efficacy-of-agn-203818-in-patients-with-painful-diabetic-peripheral-neuropathy-8189https://curecurrent.com/trials/aldosterone-and-vascular-disease-in-diabetes-mellitus-8190https://curecurrent.com/trials/measuring-cholesterol-in-the-fasting-and-postmeal-state-in-patients-with-type-2-diabetes-8191https://curecurrent.com/trials/study-evaluating-ppm-204-in-subjects-with-type-2-diabetes-8192https://curecurrent.com/trials/safety-and-efficacy-of-human-insulin-inhalation-powder-in-patients-with-type-1-diabetes-mellitus-8193https://curecurrent.com/trials/comparing-intensive-and-standard-training-for-human-insulin-inhalation-powder-hiip-8194https://curecurrent.com/trials/multi-tracer-pet-quantitation-of-skeletal-muscle-insulin-resistance-in-type-2-diabetes-mellitus-8195https://curecurrent.com/trials/effect-of-glargine-insulin-on-glucose-control-in-hospitalized-patients-who-receive-tube-feedings-8196https://curecurrent.com/trials/my-pals-a-community-based-physical-activity-support-program-for-older-adults-8197https://curecurrent.com/trials/mitochondrial-impairment-in-muscle-insulin-resistance-8198https://curecurrent.com/trials/multi-tracer-pet-quantitation-of-insulin-action-in-muscle-phase-1-phase-2-phase-3-phase-4-8199https://curecurrent.com/trials/study-of-the-safety-of-fg-3019-in-incipient-nephropathy-due-to-type-1-or-type-2-diabetes-mellitus-8200https://curecurrent.com/trials/efficacy-of-topiramate-for-weight-loss-in-subjects-with-metabolic-syndrome-8201https://curecurrent.com/trials/patient-preference-of-h-patch-vs-pen-or-needle-syringe-as-insulin-administration-device-8202https://curecurrent.com/trials/study-evaluating-single-doses-of-ppm-204-on-the-electrical-pathways-of-the-heart-8203https://curecurrent.com/trials/comparing-pre-mixed-insulin-with-insulin-glargine-combined-with-rapid-acting-insulin-in-patients-with-type-2-diabetes-8204https://curecurrent.com/trials/gene-therapy-to-improve-wound-healing-in-patients-with-diabetes-8205https://curecurrent.com/trials/telehealth-for-diabetes-self-management-8206https://curecurrent.com/trials/effect-of-rosiglitazone-on-myocardial-blood-flow-regulation-in-type-2-diabetes-8207https://curecurrent.com/trials/treatment-for-symptomatic-peripheral-neuropathy-in-patients-with-diabetes-8208https://curecurrent.com/trials/treatment-of-peripheral-neuropathy-in-patients-with-diabetes-8209https://curecurrent.com/trials/double-blind-rct-of-bicifadine-sr-in-outpatients-with-chronic-neuropathic-pain-associated-with-diabetes-8210https://curecurrent.com/trials/randomized-controlled-trial-of-laparoscopic-gastric-bypass-plus-omentectomy-versus-laparoscopic-gastric-bypass-alone-in-8211https://curecurrent.com/trials/pilot-trial-of-chromium-metformin-combination-in-type-2-diabetes-8212https://curecurrent.com/trials/in-home-weight-loss-program-for-adults-with-type-2-diabetes-delivered-by-interactive-cable-television-technology-8213https://curecurrent.com/trials/examination-of-dermatologic-effects-from-subcutaneous-injections-of-isis-113715-8214https://curecurrent.com/trials/glucose-insulin-responses-subjects-with-type-2-diabetes-consuming-diabetes-specific-vs-standard-nutritional-formulas-8215https://curecurrent.com/trials/changing-physical-activity-behavior-in-individuals-with-type-2-diabetes-using-counceling-and-information-from-continuous-8216https://curecurrent.com/trials/to-determine-the-effects-of-avosentan-on-doubling-of-serum-creatinine-end-stage-renal-disease-and-death-in-diabetic-neph-8217https://curecurrent.com/trials/treatment-of-painful-diabetic-neuropathy-with-photon-stimulation-8218https://curecurrent.com/trials/randomized-double-blind-placebo-controlled-with-phx1149-in-patients-with-type-2-diabetes-mellitus-8219https://curecurrent.com/trials/evaluation-of-glucose-lowering-effect-safety-and-tolerability-of-cs-917-8220https://curecurrent.com/trials/safety-and-efficacy-study-of-pn2034-in-type-2-diabetes-patients-on-concomitant-rosiglitazone-and-metformin-or-avandamet-8221https://curecurrent.com/trials/effects-of-pn2034-in-insulin-dependent-patients-with-type-2-diabetes-8222https://curecurrent.com/trials/exercise-training-in-older-diabetic-women-8223https://curecurrent.com/trials/safety-and-preliminary-efficacy-study-of-nicotine-gel-to-treat-diabetic-foot-ulcers-8224https://curecurrent.com/trials/tolerability-of-switching-to-duloxetine-for-the-management-of-diabetic-nerve-pain-8225https://curecurrent.com/trials/angiotensin-ii-antagonism-of-tgf-beta-1-8226https://curecurrent.com/trials/determining-the-effect-on-patients-of-internet-based-diabetes-disease-management-8227https://curecurrent.com/trials/a-phase-1-safety-study-of-tg100801-eye-drops-in-healthy-volunteers-8228https://curecurrent.com/trials/novel-home-care-device-for-high-risk-diabetic-patients-8229https://curecurrent.com/trials/shear-and-pressure-reducing-insoles-for-the-diabetic-foot-8230https://curecurrent.com/trials/the-effects-of-the-magnetic-molecular-energizer-mme-on-diabetic-peripheral-neuropathy-8231https://curecurrent.com/trials/a-study-of-attitudes-about-the-risk-of-developing-type-2-diabetes-8232https://curecurrent.com/trials/complaints-associated-with-use-of-pre-filled-pen-b-with-type-2-diabetics-on-twice-daily-insulin-8233https://curecurrent.com/trials/acute-glycemic-effects-of-a-very-low-fat-diet-in-type-2-diabetes-8234https://curecurrent.com/trials/prediction-of-ck-mb-release-during-otherwise-successful-stenting-procedure-8235https://curecurrent.com/trials/anodyne-therapy-in-diabetic-sensory-neuropathy-8236https://curecurrent.com/trials/lipid-glycemic-and-insulin-responses-to-meals-rich-in-different-fatty-acids-8237https://curecurrent.com/trials/providence-prevention-of-restenosis-with-oral-rosiglitazone-and-the-vision-stent-in-diabetics-with-coronary-lesions-8238https://curecurrent.com/trials/a-study-for-the-treatment-of-painful-diabetic-neuropathy-8239https://curecurrent.com/trials/educational-technology-to-enhance-diabetes-care-retention-study-8240https://curecurrent.com/trials/treatment-of-diabetic-retinopathy-with-open-label-anecortave-acetate-sterile-suspension-15-mg-8241https://curecurrent.com/trials/treatment-of-rubeosis-iridis-with-open-label-anecortave-acetate-sterile-suspension-15-mg-8242https://curecurrent.com/trials/comparison-of-glucovance-to-insulin-for-diabetes-during-pregnancy-8243https://curecurrent.com/trials/normal-serum-adiponectin-levels-in-females-8244https://curecurrent.com/trials/a-research-study-of-v3381-for-the-treatment-of-diabetic-peripheral-neuropathic-pain-8245https://curecurrent.com/trials/us-inhaled-insulin-therapeutic-choice-questionnaire-study-8246https://curecurrent.com/trials/monocyte-function-and-inflammation-in-type-1-diabetes-and-its-modulation-8247https://curecurrent.com/trials/six-month-clinical-trial-assessing-efficacy-and-safety-of-inhaled-insulin-in-type-2-diabetes-8248https://curecurrent.com/trials/effect-on-glycemic-control-of-inhaled-insulin-alone-or-added-to-dual-oral-therapy-after-failure-of-dual-oral-therapy-8249https://curecurrent.com/trials/six-month-clinical-trial-assessing-efficacy-and-safety-of-inhaled-insulin-in-type-1-diabetes-8250https://curecurrent.com/trials/six-month-clinical-trial-assessing-efficacy-and-safety-of-inhaled-insulin-in-type-1-diabetes-mellitus-8251https://curecurrent.com/trials/investigating-the-pharmacokinetics-and-pharmacodynamics-of-recombinant-human-insulin-administered-by-dry-powder-inhaler-8252https://curecurrent.com/trials/eye-on-diabetes-a-multidisciplinary-patient-education-intervention-8253https://curecurrent.com/trials/lifestyle-modification-for-obesity-related-type-2-diabetes-8254https://curecurrent.com/trials/maximizing-the-benefit-of-renin-angiotensin-blocking-drugs-in-diabetic-renal-disease-8255https://curecurrent.com/trials/automated-diabetes-prevention-program-8256https://curecurrent.com/trials/microvascular-reactivity-8257https://curecurrent.com/trials/the-effect-of-cinnamon-on-hba1c-among-adolescents-with-type-i-diabetes-8258https://curecurrent.com/trials/a-study-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamic-activity-of-very-low-dose-glucagon-in-subjects-w-8259https://curecurrent.com/trials/soy-protein-in-early-diabetic-nephropathy-8260https://curecurrent.com/trials/safety-efficacy-study-for-the-use-of-extracorporeal-shockwaves-in-the-treatment-of-diabetic-foot-ulcers-8261https://curecurrent.com/trials/the-effect-of-good-bacteria-on-nonalcoholic-fatty-liver-disease-in-diabetics-8262https://curecurrent.com/trials/ginkgo-biloba-extract-and-the-insulin-resistance-syndrome-8263https://curecurrent.com/trials/use-of-complementary-and-alternative-medicine-among-older-mexican-americans-8264https://curecurrent.com/trials/chromium-picolinate-for-the-treatment-of-metabolic-syndrome-8265https://curecurrent.com/trials/effects-of-reiki-on-painful-neuropathy-and-cardiovascular-risk-factors-8266https://curecurrent.com/trials/lifestyle-interventions-for-long-term-diabetes-control-8267https://curecurrent.com/trials/glad-dose-finding-efficacy-and-safety-of-az-242-tesaglitazar-in-subjects-with-type-2-diabetes-8268https://curecurrent.com/trials/behavior-therapy-for-families-of-diabetic-adolescents-8269https://curecurrent.com/trials/laser-and-medical-treatment-of-diabetic-macular-edema-8270https://curecurrent.com/trials/an-evaluation-of-an-oral-antidiabetic-agent-for-the-treatment-of-type-2-diabetes-8271https://curecurrent.com/trials/lantus-in-prediabetes-8272https://curecurrent.com/trials/bi-axial-rotating-magnetic-field-therapy-in-refractory-neuropathic-foot-pain-secondary-to-diabetic-peripheral-neuropathy-8273https://curecurrent.com/trials/effects-of-oral-glucosamine-on-insulin-and-blood-vessel-activity-in-normal-and-obese-people-8274https://curecurrent.com/trials/multidisciplinary-inpatient-palliative-care-intervention-8275https://curecurrent.com/trials/cyber-disease-management-using-the-world-wide-web-to-share-the-medical-record-with-patients-at-home-8276https://curecurrent.com/trials/a-30-day-acute-efficacy-and-safety-study-of-chromium-picolinate-biotin-on-glycemic-control-in-overweight-or-obese-subjec-8277https://curecurrent.com/trials/study-of-how-exercise-or-weight-loss-effects-metabolic-syndrome-8278https://curecurrent.com/trials/diabetes-health-enhancement-program-to-improve-health-of-people-with-diabetes-8279https://curecurrent.com/trials/temptouch-ir-thermometry-diabetic-patient-self-care-8280https://curecurrent.com/trials/doctor-patient-communication-in-spanish-8281https://curecurrent.com/trials/acute-metabolic-effects-of-laf-237-in-type-2-diabetics-8282https://curecurrent.com/trials/trial-of-new-dietary-treatment-of-diabetes-8283https://curecurrent.com/trials/ability-of-a-tea-leaf-extracts-preparation-to-slow-down-carbohydrate-and-fat-absorption-8284https://curecurrent.com/trials/shared-online-health-records-for-patient-safety-and-care-8285https://curecurrent.com/trials/hokt3gamma1-ala-ala-for-the-prevention-of-human-islet-allograft-failure-8286https://curecurrent.com/trials/pst-laser-v-laser-alone-for-csme-8287https://curecurrent.com/trials/improving-quality-with-outpatient-decision-support-8288https://curecurrent.com/trials/insulin-glargine-vs-standard-insulin-therapy-8289https://curecurrent.com/trials/diabetes-knowledge-assessment-8290https://curecurrent.com/trials/type-2-diabetes-controlled-eating-experiment-8291https://curecurrent.com/trials/long-term-free-living-study-with-modified-foods-and-type-2-diabetics-8292https://curecurrent.com/trials/prevalence-of-carbohydrate-intolerance-in-lean-and-obese-children-8293https://curecurrent.com/trials/prospective-controlled-study-of-posttransplant-diabetes-8294https://curecurrent.com/trials/patterns-and-natural-history-of-insulin-secretion-in-islet-cell-transplant-recipients-and-controls-8295https://curecurrent.com/trials/lactobacillus-plantarum-as-therapy-for-nk-t-cell-deficiency-8296https://curecurrent.com/trials/modification-of-the-edmonton-protocol-to-allow-for-successful-islet-transplantation-from-a-single-pancreas-and-extension-8297https://curecurrent.com/trials/lidorestat-idd-676-for-the-treatment-of-diabetic-neuropathy-8298https://curecurrent.com/trials/ingested-interferon-alpha-prolongation-or-permanence-of-the-honeymoon-phase-in-newly-diagnosed-type-1-diabetes-mellitus-8299https://curecurrent.com/trials/screening-adolescents-for-type-2-diabetes-mellitus-in-a-community-clinic-8300https://curecurrent.com/trials/a-clinical-trial-to-prevent-the-complications-of-insulin-resistance-including-type-2-diabetes-8301https://curecurrent.com/trials/nnc-90-1170-mechanism-of-action-a-double-blind-randomized-single-center-placebo-controlled-crossover-study-to-examine-be-8302https://curecurrent.com/trials/study-of-the-pathogenesis-and-pathophysiology-of-familial-neurohypophyseal-diabetes-insipidus-8303https://curecurrent.com/trials/achilles-tendon-lengthening-in-patients-with-diabetes-to-prevent-foot-ulcers-8304https://curecurrent.com/trials/how-shoes-with-rocker-soles-affect-walking-8305https://curecurrent.com/trials/single-dose-and-34-day-tolerance-study-of-ingap-peptide-in-insulin-deficient-patients-8306https://curecurrent.com/trials/biomarkers-of-steatohepatitis-in-type-2-diabetes-patients-8307https://curecurrent.com/trials/prevalence-and-determinants-of-therapeutic-non-compliance-in-patients-with-chronic-pathologies-pdtnccp-8308https://curecurrent.com/trials/tracking-income-dynamics-and-everyday-health-study-8309https://curecurrent.com/trials/multinational-point-prevalence-study-on-the-management-of-diabesity-in-hospitals-8310https://curecurrent.com/trials/evaluation-of-minimed-next-generation-extended-wear-sensors-and-algorithm-in-patients-with-type-1-and-type-2-diabetes-8311https://curecurrent.com/trials/group-education-trial-to-improve-transition-for-parents-of-adolescents-with-t1d-8312https://curecurrent.com/trials/digidiab-pilot-impact-study-hospital-8313https://curecurrent.com/trials/strategy-for-assessing-the-risk-of-type-1-diabetes-in-pediatric-celiac-patients-8314https://curecurrent.com/trials/evaluation-of-neurodevelopmental-trajectories-in-children-according-to-the-glycemic-profile-associated-with-early-treatm-8315https://curecurrent.com/trials/visceral-adipose-tissue-and-liver-changes-associated-with-semaglutide-in-ckd-8316https://curecurrent.com/trials/effects-of-high-intensity-interval-training-and-quinoa-supplementation-in-women-with-type-2-diabetes-8317https://curecurrent.com/trials/on-the-move-center-and-home-based-exercise-to-enhance-mobility-in-diabetic-foot-ulcer-recovery-8318https://curecurrent.com/trials/prevalence-of-diabetes-related-distress-among-patients-living-with-type-2-diabetes-in-a-university-hospital-center-and-i-8319https://curecurrent.com/trials/effect-of-probiotics-versus-metformin-on-glycemic-control-insulin-sensitivity-and-insulin-secretion-in-prediabetes-8320https://curecurrent.com/trials/continuous-delivery-of-ranibizumab-via-the-port-delivery-system-for-proliferative-diabetic-retinopathy-related-vitreous-8321https://curecurrent.com/trials/digidiab-pilot-spain-nursing-home-and-domiciliary-nursing-care-8322https://curecurrent.com/trials/a-phase-iii-study-to-evaluate-the-efficacy-and-safety-of-petrelintide-in-participants-with-overweight-or-obesity-and-typ-8323https://curecurrent.com/trials/gastric-ultrasound-after-clear-fluid-intake-in-diabetic-and-non-diabetic-pregnant-women-8324https://curecurrent.com/trials/effectiveness-and-safety-of-tirzepatide-among-participants-with-obesity-with-or-without-type-2-diabetes-mellitus-t2dm-8325https://curecurrent.com/trials/efficacy-and-safety-of-sanggua-tablets-in-the-treatment-of-patients-with-impaired-glucose-tolerance-and-mild-type-2-diab-8326https://curecurrent.com/trials/a-trial-to-evaluate-the-efficacy-and-safety-of-aro-inhbe-in-adults-with-metabolic-dysfunction-associated-steatohepatitis-8327https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-retatrutide-on-insulin-secretion-and-insulin-sensitivity-in-adult-participants-with-ty-8328https://curecurrent.com/trials/effect-of-artificial-sweetener-afs-on-glucose-metabolism-in-patients-with-type-1-diabetes-t1d-8329https://curecurrent.com/trials/nmr-metabolomics-based-risk-assessment-and-stratified-digital-health-interventions-in-middle-aged-adults-premap-8330https://curecurrent.com/trials/diabetes-distress-medication-adherence-barriers-self-management-and-glycemic-control-in-adults-with-type-2-diabetes-8331https://curecurrent.com/trials/colchicine-and-non-enteric-coated-aspirin-in-the-cardiovascular-outcomes-trial-of-patients-with-type-2-diabetes-8332https://curecurrent.com/trials/reset-inspire-study-insulin-sensitivity-population-intervention-with-real-time-evaluation-using-cgm-8333https://curecurrent.com/trials/para-probiotic-oral-care-in-periodontal-patients-with-type-2-diabetes-8334https://curecurrent.com/trials/prevention-of-diabetes-after-transplantation-by-vildagliptin-in-the-early-post-transplant-period-8335https://curecurrent.com/trials/a-study-of-ly3938577-in-healthy-participants-and-participants-with-type-1-diabetes-mellitus-t1dm-8336https://curecurrent.com/trials/taining-golden-lake-comprehensive-chronic-disease-management-initiative-8337https://curecurrent.com/trials/diabuddy-ai-enabled-digital-self-management-for-youth-with-type-1-diabetes-8338https://curecurrent.com/trials/food-prescription-among-youth-with-type-1-diabetes-8339https://curecurrent.com/trials/balanced-multi-electrolyte-solution-versus-saline-trial-for-diabetic-ketoacidosis-8340https://curecurrent.com/trials/the-effect-of-oral-semaglutide-on-bone-turnover-in-patients-with-t2d-a-randomized-placebo-controlled-clinical-trial-8341https://curecurrent.com/trials/vv-14299-and-vv-14300-for-the-treatment-of-type-1-diabetes-8342https://curecurrent.com/trials/vv-14300-for-the-treatment-of-type-1-diabetes-8343https://curecurrent.com/trials/awareness-of-bidirectional-relation-of-diabetes-mellitus-and-periodontal-health-8344https://curecurrent.com/trials/evaluation-of-fuling-yunhua-granules-and-dihuang-baoyuan-granules-in-drug-naive-type-2-diabetes-patients-8345https://curecurrent.com/trials/glp-1-receptor-agonist-use-and-sarcopenia-in-obese-individuals-without-diabetes-8346https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-efficacy-of-sys6088-in-patients-with-advanced-metastati-8347https://curecurrent.com/trials/personalised-medicine-in-pre-diabetes-and-early-type-2-diabetes-8348https://curecurrent.com/trials/a-study-to-assess-effect-of-glucocil-on-metabolic-health-in-individuals-with-prediabetes-and-type-2-diabetes-mellitus-8349https://curecurrent.com/trials/system-accuracy-of-the-blood-glucose-monitor-for-personal-use-aria-8350https://curecurrent.com/trials/bb-101-for-the-treatment-of-diabetic-lower-leg-and-foot-ulcers-8351https://curecurrent.com/trials/effect-of-otago-vs-sensorimotor-training-on-balance-and-fall-risk-in-people-with-diabetes-8352https://curecurrent.com/trials/dietary-strategies-for-remission-of-type-2-diabetes-8353https://curecurrent.com/trials/remotely-delivered-mindfulness-based-diabetes-education-8354https://curecurrent.com/trials/multimodal-risk-factor-graph-mapping-metabolic-subtyping-and-digital-intelligent-chronic-disease-management-for-prediabe-8355https://curecurrent.com/trials/clinical-predictors-and-therapeutic-gaps-in-ckm-syndrome-among-adults-with-type-2-diabetes-8356https://curecurrent.com/trials/educational-intervention-in-the-first-18-months-of-life-to-prevent-manage-obesity-of-children-after-gestational-diabetes-8357https://curecurrent.com/trials/peel-family-diabetes-prevention-program-8358https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-implementing-a-screening-strategy-for-the-diagnosis-of-prediabetes-and-type-2-diabete-8359https://curecurrent.com/trials/educational-intervention-for-self-care-in-patients-with-coronary-heart-disease-and-type-2-diabetes-8360https://curecurrent.com/trials/effectiveness-of-personalized-oral-hygiene-advice-delivered-by-artificial-intelligence-or-dental-professionals-versus-st-8361https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-elecoglipron-in-asian-participants-with-obesity-or-overweight-with-or-8362https://curecurrent.com/trials/a-controlled-prospective-treatment-study-to-evaluate-the-efficacy-of-vendaje-8363https://curecurrent.com/trials/combined-treatment-for-non-healing-wounds-in-chronic-lower-extremity-arterial-disease-a-comparative-study-8364https://curecurrent.com/trials/impact-of-time-restricted-eating-on-metabolic-homeostasis-inflammation-and-oxidative-stress-in-metabolic-syndrome-8365https://curecurrent.com/trials/glucose-dependent-insulinotropic-polypeptide-effect-on-bone-remodelling-and-cell-activity-ginebra-8366https://curecurrent.com/trials/effect-of-golden-rice-piper-crocatum-cookies-on-neuropathy-prevention-in-diabetes-8367https://curecurrent.com/trials/functional-mobility-and-resistance-exercise-for-postmenopausal-females-with-type-1-diabetes-8368https://curecurrent.com/trials/prevalence-of-renal-insufficiency-in-patients-with-type-2-diabetes-8369https://curecurrent.com/trials/lumbopelvic-stability-in-gestational-diabetes-mellitus-8370https://curecurrent.com/trials/pancreatin-added-to-standard-antihyperglycemic-therapy-in-patients-with-type-2-diabetes-8371https://curecurrent.com/trials/effect-of-mhealth-intervention-on-oral-health-related-quality-of-life-among-adult-patients-with-chronic-systemic-disease-8372https://curecurrent.com/trials/glycemic-control-and-quality-of-life-evolution-for-patients-with-t1d-using-the-myloop-powered-by-camaps-fx-system-in-com-8373https://curecurrent.com/trials/the-effect-of-message-framing-in-diabetic-foot-self-management-8374https://curecurrent.com/trials/a-study-to-compare-the-use-of-diabetes-treatment-support-system-bap0527-and-blood-glucose-meter-in-addition-to-daily-pra-8375https://curecurrent.com/trials/outcome-of-complete-pulpotomy-in-healthy-and-type-2-diabetic-patients-in-permanent-teeth-with-irreversible-pulpitis-8376https://curecurrent.com/trials/evaluation-of-the-simba-capsule-for-small-intestinal-dysbiosis-8377https://curecurrent.com/trials/the-effect-of-different-auditory-types-on-visual-evoked-potentials-vep-8378https://curecurrent.com/trials/inter-device-concordance-of-plantar-thermal-asymmetry-measurement-hik-dm-2026-8379https://curecurrent.com/trials/a-retrospective-real-world-cohort-study-8380https://curecurrent.com/trials/convenient-home-access-for-routine-monitoring-in-diabetes-charm-d-study-8381https://curecurrent.com/trials/korean-study-on-safety-and-effectiveness-of-oad-triple-therapy-in-type-2-diabetes-8382https://curecurrent.com/trials/preoperative-gastric-volume-and-high-risk-gastric-content-in-patients-with-type-2-diabetes-mellitus-8383https://curecurrent.com/trials/a-series-of-pilot-studies-to-evaluate-the-haemodynamic-and-metabolic-effects-of-apelin-and-relaxin-8384https://curecurrent.com/trials/adaptation-implementation-and-validation-of-an-innovative-ehealth-system-for-the-self-management-monitoring-and-speciali-8385https://curecurrent.com/trials/nurse-led-self-management-and-breathing-intervention-in-type-2-diabetes-8386https://curecurrent.com/trials/the-effectiveness-of-an-occupation-based-lifestyle-program-in-individuals-with-type-2-diabetes-8387https://curecurrent.com/trials/jak1-inhibitor-ivarmacitinib-for-improving-pancreatic-islet-function-in-t1d-8388https://curecurrent.com/trials/diabetes-glycemic-assessment-in-newly-confirmed-episodes-8389https://curecurrent.com/trials/continuous-ketone-monitoring-in-people-with-type-1-diabetes-using-sglt2-inhibitors-8390https://curecurrent.com/trials/precise-eating-time-to-improve-glycemic-control-and-cardiometabolic-health-in-prediabetes-and-diabetes-8391https://curecurrent.com/trials/soluble-trem-1-in-diabetes-associated-cardiovascular-complications-8392https://curecurrent.com/trials/diafootcare-to-promote-self-care-of-diabetic-foot-ulcers-in-oman-8393https://curecurrent.com/trials/the-lifemeds-cohort-8394https://curecurrent.com/trials/prediabetes-glycemic-impact-and-data-evaluation-8395https://curecurrent.com/trials/effect-of-weekly-glp1-agonist-treatment-in-double-diabetes-8396https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-ro7204239-on-insulin-sensitivity-and-muscle-composition-in-participants-with-type-2-di-8397https://curecurrent.com/trials/home-ahcl-home-based-implementation-of-an-advanced-hybrid-closed-loop-system-with-telemonitoring-in-type-1-diabetes-8398https://curecurrent.com/trials/protein-rich-meals-to-control-glucose-8399https://curecurrent.com/trials/probiotics-in-obese-patients-treated-with-glp-1-receptor-agonists-8400https://curecurrent.com/trials/the-precision-t2d-study-precision-nutrition-study-for-type-2-diabetes-8401https://curecurrent.com/trials/aim-weight-ai-guided-microbiome-targeted-nutritional-intervention-for-weight-loss-8402https://curecurrent.com/trials/a-study-of-ly4057996-in-healthy-participants-and-participants-with-type-1-and-type-2-diabetes-8403https://curecurrent.com/trials/platelet-indices-and-blood-groups-in-type-2-diabetes-vascular-complications-8404https://curecurrent.com/trials/evaluating-the-efficacy-and-quality-of-life-impact-of-transitioning-to-advanced-hybrid-closed-loop-insulin-pump-therapy-8405https://curecurrent.com/trials/impact-of-dietary-intervention-within-an-interprofessional-cooperative-protocol-for-prandial-insulin-dose-adjustment-in-8406https://curecurrent.com/trials/a-study-of-ly900014-in-adult-participants-with-type-2-diabetes-mellitus-in-india-8407https://curecurrent.com/trials/proteome-wide-association-and-llm-based-prioritization-of-type-2-diabetes-protein-targets-8408https://curecurrent.com/trials/clinical-study-to-evaluate-the-impact-of-the-accu-chek-smartguide-cgm-solution-on-the-mean-change-in-time-in-range-compa-8409https://curecurrent.com/trials/a-cluster-randomized-controlled-trial-8410https://curecurrent.com/trials/effects-of-antipsychotics-on-brain-insulin-action-in-females-8411https://curecurrent.com/trials/diabetes-insulin-gut-enteric-supplementation-trial-8412https://curecurrent.com/trials/gastrointestinal-symptoms-in-children-with-type-1-diabetes-8413https://curecurrent.com/trials/structured-carbohydrate-counting-education-in-adults-with-type-1-diabetes-8414https://curecurrent.com/trials/a-study-of-hrs-4729-injection-in-participants-with-type-2-diabetes-8415https://curecurrent.com/trials/surveillance-of-pancreatic-health-after-diabetes-diagnosis-8416https://curecurrent.com/trials/genetics-of-type-2-diabetes-in-west-africans-8417https://curecurrent.com/trials/a-efficacy-and-safety-study-of-ranibizumab-10mg-ml-injection-incepta-in-patients-with-diabetic-macular-edema-8418https://curecurrent.com/trials/the-effect-of-light-therapy-on-cellular-energy-and-oxidative-stress-in-healthy-adults-and-type-1-diabetic-patients-8419https://curecurrent.com/trials/body-composition-changes-after-initiation-of-glp-1-receptor-agonists-in-adults-with-obesity-or-type-2-diabetes-8420https://curecurrent.com/trials/pathogenicity-factors-of-staphylococcus-pettenkoferi-in-foot-wounds-and-osteitis-in-diabetic-patients-8421https://curecurrent.com/trials/tibial-nerve-mobilization-versus-multisensory-exercises-in-patients-with-diabetic-foot-ulcer-8422https://curecurrent.com/trials/evaluating-autologous-platelet-rich-fibrin-plasma-for-chronic-diabetic-foot-ulcers-8423https://curecurrent.com/trials/phase-3-study-of-intravitreal-oln324-in-adults-with-diabetic-macular-edema-dme-oln324-cp-03-8424https://curecurrent.com/trials/wenzhou-gestational-diabetes-cohort-8425https://curecurrent.com/trials/continuous-ketone-monitoring-in-people-with-type-1-diabetes-using-sglt2-inhibitors-8426https://curecurrent.com/trials/exercise-and-tissue-specific-insulin-sensitivity-in-south-asian-and-nordic-women-with-previous-gestational-diabetes-8427https://curecurrent.com/trials/a-study-on-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-hrs-1596-tablets-in-healthy-participants-wit-8428https://curecurrent.com/trials/negative-pressure-wound-therapy-devices-in-total-knee-arthroplasty-8429https://curecurrent.com/trials/a-research-study-to-see-how-insulin-icodec-helps-people-with-type-1-diabetes-control-their-blood-sugar-8430https://curecurrent.com/trials/evaluation-of-a-new-virtual-care-pathway-for-older-adults-with-noncommunicable-diseases-a-pilot-study-at-the-national-un-8431https://curecurrent.com/trials/traditional-chinese-medicine-fasting-therapy-ketone-levels-and-metabolic-improvements-8432https://curecurrent.com/trials/night-hyperglycemia-and-fatty-liver-in-type-1-diabetes-8433https://curecurrent.com/trials/a-study-to-learn-more-about-how-well-finerenone-works-in-real-world-in-people-with-type-2-diabetes-and-chronic-kidney-di-8434https://curecurrent.com/trials/studies-of-blood-glucose-and-the-microbiome-in-tumors-and-cysts-of-the-pancreas-8435https://curecurrent.com/trials/combination-of-lactulose-and-polyethylene-glycol-electrolytes-powder-peg-els-for-bowel-preparation-in-type-ii-diabetes-m-8436https://curecurrent.com/trials/phase-3-study-of-intravitreal-oln324-in-adults-with-diabetic-macular-edema-dme-oln324-cp-02-8437https://curecurrent.com/trials/westlake-precision-birth-cohort-8438https://curecurrent.com/trials/pharmacokinetics-safety-and-immunogenicity-comparison-of-bmab1700-and-opdivo-as-adjuvant-monotherapy-in-participants-wit-8439https://curecurrent.com/trials/a-first-in-human-study-of-aro-inhbe-in-adults-with-obesity-with-and-without-type-2-diabetes-mellitus-8440https://curecurrent.com/trials/activity-reduction-vs-advice-for-plantar-hotspots-in-diabetes-8441https://curecurrent.com/trials/diastolic-dysfunction-and-pulmonary-hypertension-in-t2dm-with-microalbuminuria-8442https://curecurrent.com/trials/impact-of-endoscopic-sleeve-gastroplasty-esg-in-obese-adults-with-type-2-diabetes-t2d-8443https://curecurrent.com/trials/a-pan-european-post-authorisation-safety-study-risk-of-pancreatic-cancer-among-type-2-diabetes-patients-who-initiated-ex-8444https://curecurrent.com/trials/clinican-bead-t1d-building-the-evidence-to-address-disengagement-in-type-1-diabetes-8445https://curecurrent.com/trials/oromucosal-oxytocin-and-vasopressin-modulation-of-emotional-face-attention-8446https://curecurrent.com/trials/neurovascular-coupling-and-autonomic-neuropathy-in-type-2-diabetes-8447https://curecurrent.com/trials/ai-based-phenome-data-analysis-for-predicting-the-onset-of-major-diseases-8448https://curecurrent.com/trials/usability-study-of-the-sensors-and-emom-gdm-application-8449https://curecurrent.com/trials/colchicine-for-primary-prevention-of-cardiovascular-disease-in-adults-with-type-2-diabetes-8450https://curecurrent.com/trials/adherence-to-clinical-guidelines-for-management-of-patients-with-type-2-diabetes-mellitus-and-obesity-8451https://curecurrent.com/trials/taurine-effect-on-glycemic-lipidic-and-inflammatory-profile-in-individuals-with-type-2-diabetes-8452https://curecurrent.com/trials/ehealth-in-treatment-of-gestational-diabetes-emomgdm-8453https://curecurrent.com/trials/the-effect-of-in-utero-exposure-to-metformin-in-5-11-year-old-offspring-of-mothers-in-the-mity-trial-8454https://curecurrent.com/trials/therapeutic-adherence-in-type-2-diabetes-8455https://curecurrent.com/trials/pre-exercise-whey-and-pea-protein-in-adolescents-with-type-1-diabetes-8456https://curecurrent.com/trials/the-evaluation-of-the-drug-r3r01-for-the-excretion-of-protein-in-the-urine-in-patients-with-diabetic-kidney-disease-8457https://curecurrent.com/trials/the-dapa-memri-trial-8458https://curecurrent.com/trials/improving-health-literacy-on-chronic-kidney-disease-among-diabetics-the-malaysian-nutritional-emotional-and-physical-hea-8459https://curecurrent.com/trials/bioequivalence-study-of-chiglitazar-metformin-extended-release-tablets-8460https://curecurrent.com/trials/non-interventional-study-nis-on-sodium-glucose-co-transporter-2-inhibitors-sglt2i-use-in-france-8461https://curecurrent.com/trials/biased-grk-signaling-via-2-adrenergic-receptors-in-human-skeletal-muscle-8462https://curecurrent.com/trials/serum-sulfate-and-brain-function-in-diabetic-encephalopathy-8463https://curecurrent.com/trials/environmental-determinants-of-type-1-diabetes-risk-8464https://curecurrent.com/trials/a-clinical-study-on-using-multimodal-ultrasound-to-assess-muscle-mass-in-metabolic-diseases-8465https://curecurrent.com/trials/pilot-bioequivalence-study-of-chiglitazar-metformin-extended-release-tablets-8466https://curecurrent.com/trials/freestyle-libre-glucose-monitoring-system-paediatric-study-8467https://curecurrent.com/trials/morphological-pancreatic-features-in-diabetes-mellitus-type-2-8468https://curecurrent.com/trials/moringa-leaf-powder-for-prediabetes-8469https://curecurrent.com/trials/dual-task-versus-combined-exercise-training-in-older-adults-with-type-2-diabetes-8470https://curecurrent.com/trials/a-multicenter-randomized-double-blind-trial-of-chrocare-cdss-for-integrated-management-of-type-2-diabetes-8471https://curecurrent.com/trials/jejunal-luminal-and-colonic-mucosa-associated-microbiota-in-metabolic-diseases-methods-identification-and-causalities-8472https://curecurrent.com/trials/incretin-therapy-and-exercise-in-type-2-diabetes-8473https://curecurrent.com/trials/a-study-of-orforglipron-ly3502970-in-participants-with-type-2-diabetes-who-observe-ramadan-fasting-8474https://curecurrent.com/trials/clinical-evaluation-of-the-medtronic-implantable-insulin-pump-system-miips-2020-in-adult-subjects-with-type-1-diabetes-c-8475https://curecurrent.com/trials/ai-cimcare-chatbot-to-enhance-complementary-and-integrative-medicine-cim-8476https://curecurrent.com/trials/weekly-glp-1-receptor-agonists-in-obese-individuals-without-diabetes-8477https://curecurrent.com/trials/cranberry-proanthocyanidins-and-lactobacilli-for-recurrent-uti-prevention-in-type-2-diabetes-8478https://curecurrent.com/trials/healthy-habits-during-and-after-gestational-diabetes-8479https://curecurrent.com/trials/the-wait-trial-waiting-versus-active-induction-at-term-in-women-with-a1-gestational-diabetes-mellitus-8480https://curecurrent.com/trials/incidence-and-clinical-features-of-breakthrough-pain-after-brachial-plexus-block-in-diabetic-patients-8481https://curecurrent.com/trials/effect-of-proso-millet-based-bread-on-postprandial-glycemic-response-in-adults-with-type-2-diabetes-8482https://curecurrent.com/trials/effect-of-tens-on-sensory-parameters-in-diabetic-polyneuropathy-8483https://curecurrent.com/trials/evaluation-of-the-safety-and-performance-of-the-novel-medtronic-experimental-automated-insulin-delivery-system-nmx8-in-p-8484https://curecurrent.com/trials/use-of-continuous-glucose-monitoring-devices-among-people-living-with-type-1-diabetes-in-kenya-8485https://curecurrent.com/trials/evaluation-of-pharmacist-intervention-for-individuals-with-uncontrolled-type-2-diabetes-8486https://curecurrent.com/trials/drawing-and-writing-activities-in-adolescents-with-type-1-diabetes-8487https://curecurrent.com/trials/effectiveness-of-urdiacare-8488https://curecurrent.com/trials/very-low-carbohydrate-diet-for-prediabetes-and-obesity-8489https://curecurrent.com/trials/a-study-intravitreal-thn391-in-diabetic-macular-oedema-secondary-to-non-proliferative-diabetic-retinopathy-8490https://curecurrent.com/trials/epalrestat-combined-with-haic-donafenib-and-tislelizumab-as-first-line-treatment-for-patients-with-unresectable-hcc-and-8491https://curecurrent.com/trials/biological-profiles-of-neuropeptides-neurotrophins-and-mirna-in-migraine-8492https://curecurrent.com/trials/nature-image-exposure-in-type-2-diabetes-8493https://curecurrent.com/trials/team-based-shared-decision-making-program-in-cardiovascular-kidney-metabolic-health-8494https://curecurrent.com/trials/distinguishing-patient-groups-using-autonomic-dysfunction-8495https://curecurrent.com/trials/preoperative-oral-carbohydrate-loading-in-patients-with-type-2-diabetes-undergoing-gastrointestinal-surgery-8496https://curecurrent.com/trials/ubt251-injection-phase-ii-type-2-diabetes-mellitus-study-8497https://curecurrent.com/trials/translational-study-using-human-abdominal-adipose-tissue-biopsies-to-investigate-the-role-of-cannabinoid-receptor-1-cb1-8498https://curecurrent.com/trials/the-role-of-hormonal-and-metabolic-disorders-in-the-debelopment-of-gestational-diabetes-mellitus-8499https://curecurrent.com/trials/mindful-eating-and-mindful-movement-for-persons-with-type-2-diabetes-mellitus-8500https://curecurrent.com/trials/involvement-of-muscle-mitochondrial-dysfunction-in-frailty-in-older-adults-role-of-exercise-8501https://curecurrent.com/trials/a-pragmatic-trial-comparing-empagliflozin-and-dapagliflozin-through-cluster-randomization-embedded-in-the-electronic-hea-8502https://curecurrent.com/trials/a-research-study-to-examine-blood-sugar-control-treatment-satisfaction-and-adherence-in-people-with-type-2-diabetes-afte-8503https://curecurrent.com/trials/the-cognitive-protective-effect-of-vr-based-cognitive-training-in-type-2-diabetes-patients-with-mild-cognitive-impairmen-8504https://curecurrent.com/trials/comparative-effects-of-reactive-balance-training-and-task-oriented-training-on-postural-stability-in-patients-with-diabe-8505https://curecurrent.com/trials/regulatory-post-marketing-surveillance-rpms-study-of-rybelsus-oral-semaglutide-to-evaluate-safety-and-effectiveness-in-p-8506https://curecurrent.com/trials/feasibility-and-effectiveness-of-tele-diabetes-remote-system-on-glycemic-control-and-quality-of-life-of-children-and-you-8507https://curecurrent.com/trials/seltoplasmid-plus-revascularization-for-diabetic-infrapopliteal-chronic-limb-threatening-ischemia-8508https://curecurrent.com/trials/benefits-of-retained-insulin-for-good-health-8509https://curecurrent.com/trials/conception-of-a-diagnosis-prognosis-and-therapeutic-decision-tool-for-patients-with-autoimmunity-and-inflammation-8510https://curecurrent.com/trials/mulligan-mobilization-with-movement-versus-conventional-physiotherapy-on-ankle-range-of-motion-mobility-pain-and-quality-8511https://curecurrent.com/trials/nutritional-status-in-adults-with-diabetic-foot-ulcers-8512https://curecurrent.com/trials/randomized-double-blind-trial-on-safety-and-efficacy-of-nanordica-advanced-antibacterial-wound-dressing-for-diabetic-foo-8513https://curecurrent.com/trials/screening-for-diabetic-retinopathy-using-a-non-mydriatic-retinograph-funduscope-in-occupational-medicine-8514https://curecurrent.com/trials/continuous-glucose-monitoring-versus-self-monitoring-of-blood-glucose-in-women-with-gestational-diabetes-8515https://curecurrent.com/trials/effects-of-ph3-in-diabetic-nephropathy-8516https://curecurrent.com/trials/bgm-and-hba1c-poc-device-evaluation-8517https://curecurrent.com/trials/efficacy-of-melatonin-in-the-treatment-of-diabetic-nephropathy-compared-with-folic-acid-8518https://curecurrent.com/trials/glycemic-control-and-the-ask-me-3-educational-program-8519https://curecurrent.com/trials/usability-evaluation-of-gen-ai-based-nutrition-chatbot-for-pregnant-women-8520https://curecurrent.com/trials/dyadic-management-intervention-in-older-people-with-co-occurring-cognitive-impairment-and-diabetes-as-a-supplementary-ap-8521https://curecurrent.com/trials/patterns-and-glycaemic-endpoints-for-diagnosing-gestational-diabetes-8522https://curecurrent.com/trials/metabolic-syndrome-and-prediabetes-8523https://curecurrent.com/trials/just-in-time-adaptive-interventions-for-diabetic-patients-8524https://curecurrent.com/trials/the-effects-of-virtual-reality-and-stress-ball-application-on-pain-anxiety-levels-and-injection-satisfaction-in-during-i-8525https://curecurrent.com/trials/effects-of-acetyl-l-carnitine-supplementation-on-clinical-metabolic-and-inflammatory-symptoms-in-obese-diabetic-postmeno-8526https://curecurrent.com/trials/clinical-study-analysis-of-glycemic-control-and-satisfaction-with-a-connected-smart-cap-in-patients-with-type-1-diabetes-8527https://curecurrent.com/trials/probiotic-impact-on-cognitive-performance-and-metabolic-outcomes-in-overweight-young-adults-with-impaired-glucose-regula-8528https://curecurrent.com/trials/optimizing-implementation-of-the-intensive-diabetes-prevention-program-8529https://curecurrent.com/trials/evaluation-of-the-psychometric-properties-of-the-turkish-version-of-the-hypoglycaemia-self-care-behaviour-scale-8530https://curecurrent.com/trials/doxycycline-in-type-ii-diabetes-8531https://curecurrent.com/trials/acute-metabolic-effects-of-tirzepatide-in-type-1-diabetes-8532https://curecurrent.com/trials/semaglutide-for-the-prevention-of-post-transplant-diabetes-mellitus-8533https://curecurrent.com/trials/impact-of-golden-rice-piper-crocatum-cookies-on-lipid-control-in-diabetes-mellitus-patients-8534https://curecurrent.com/trials/leukocyte-glucose-index-and-severity-of-diabetic-ketoacidosis-8535https://curecurrent.com/trials/fear-of-hypoglycemia-in-patients-with-diabetes-8536https://curecurrent.com/trials/healthcare-practitioners-knowledge-on-diabetes-technology-8537https://curecurrent.com/trials/a-single-dose-pharmacokinetic-study-of-hrs-4729-injection-in-healthy-participants-and-patients-with-renal-impairment-8538https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ad-233a-ad-233b-ad-233c-and-or-ad-233d-combination-therapy-8539https://curecurrent.com/trials/effect-of-silver-nanoparticles-phonophoresis-on-diabetic-foot-ulcer-heeling-8540https://curecurrent.com/trials/effect-of-an-early-and-intensified-nutritional-intervention-on-the-risk-of-developing-gestational-diabetes-mellitus-8541https://curecurrent.com/trials/a-novel-miniature-equine-assisted-diabetes-education-program-for-youth-evaluating-the-diabetes-equine-empowerment-progra-8542https://curecurrent.com/trials/human-umbilical-cord-mesenchymal-stem-cell-injection-for-diabetic-nephropathy-8543https://curecurrent.com/trials/polypills-approach-for-multiple-cardiovascular-risk-factors-8544https://curecurrent.com/trials/endoscopic-sleeve-gastroplasty-plus-duodenal-pulsendo-for-obese-t2dm-8545https://curecurrent.com/trials/neuropathic-pain-and-type-ii-diabetic-patients-8546https://curecurrent.com/trials/perfusion-index-for-predicting-diabetic-ketoacidosis-severity-in-the-emergency-department-8547https://curecurrent.com/trials/efficacy-and-safety-of-oral-controlled-release-nicotinic-acid-cir-na-for-the-remission-of-prediabetes-concept-8548https://curecurrent.com/trials/a-food-effect-study-of-cx11-in-healthy-participants-8549https://curecurrent.com/trials/a-study-evaluating-the-safety-of-inavolisib-and-fulvestrant-with-or-without-palbociclib-in-participants-with-advanced-br-8550https://curecurrent.com/trials/menstrual-cycle-mapping-while-using-closed-loop-insulin-delivery-8551https://curecurrent.com/trials/predictive-value-of-fetal-modified-myocardial-performance-index-for-adverse-perinatal-outcomes-in-late-onset-preeclampsi-8552https://curecurrent.com/trials/human-genes-and-microbiota-in-early-life-8553https://curecurrent.com/trials/neurofeedback-for-the-management-of-neuropathic-pain-in-people-with-diabetes-8554https://curecurrent.com/trials/impact-of-sevoflurane-versus-propofol-on-postoperative-delirium-in-elderly-diabetic-patients-undergoing-non-cardiac-surg-8555https://curecurrent.com/trials/effects-of-a-mediterranean-diet-with-sequential-cycling-and-rowing-exercise-on-blood-sugar-in-women-with-prediabetes-or-8556https://curecurrent.com/trials/duodenal-pulsendo-for-suboptimally-controlled-type-ii-diabetes-mellitus-and-steatotic-liver-disease-8557https://curecurrent.com/trials/a-pivotal-clinical-investigation-confirming-the-safety-and-accuracy-of-the-glyconics-ds-in-assessment-of-glycated-nail-k-8558https://curecurrent.com/trials/polyneuropathy-impairments-and-physical-activity-the-polyimpact-study-8559https://curecurrent.com/trials/reconfirming-the-safety-and-performance-of-the-glyconics-ds-system-in-known-populations-with-and-without-diabetes-8560https://curecurrent.com/trials/early-pregnancy-lifestyle-and-glucose-patterns-a-substudy-of-tofffy-8561https://curecurrent.com/trials/duodenal-pulsendo-as-an-early-treatment-for-type-2-dm-8562https://curecurrent.com/trials/the-association-of-maternal-night-eating-pattern-with-glucose-tolerance-during-pregnancy-8563https://curecurrent.com/trials/semaglutide-for-the-treatment-of-glucose-intolerance-in-women-with-prior-gestational-diabetes-8564https://curecurrent.com/trials/health-assessment-of-low-glycaemic-index-high-protein-rice-to-enhance-glycemic-control-through-nutrition-8565https://curecurrent.com/trials/patients-with-type-2-diabetes-8566https://curecurrent.com/trials/laser-photocoagulation-and-ranibizumab-treatment-in-proliferative-diabetic-retinopathy-8567https://curecurrent.com/trials/research-study-to-examine-blood-sugar-control-treatment-satisfaction-and-adherence-in-people-with-type-2-diabetes-after-8568https://curecurrent.com/trials/efficacy-of-educational-nutrition-and-exercise-on-the-regulation-of-appetite-through-exosomes-in-type-2-diabetics-8569https://curecurrent.com/trials/the-use-of-social-media-platform-to-continuously-support-pregnant-women-with-gestational-diabetes-mellitus-8570https://curecurrent.com/trials/a-phase-i-study-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-single-subcutaneous-ubt38006-injecti-8571https://curecurrent.com/trials/comparative-study-of-different-weekly-glp-1-receptor-agonists-among-diabetic-and-non-diabetic-patients-clinical-trial-8572https://curecurrent.com/trials/phase-iii-study-of-ubt251-injection-in-patients-with-type-2-diabetes-mellitus-with-inadequate-glycemic-control-on-diet-a-8573https://curecurrent.com/trials/pre-emptive-insulin-to-prevent-high-glucose-after-a-knee-steroid-injection-in-adults-with-type-2-diabetes-8574https://curecurrent.com/trials/the-effect-of-time-restricted-eating-in-24-hour-metabolic-homeostasis-and-diurnal-rhythm-8575https://curecurrent.com/trials/nutcracker-can-almond-nut-consumption-improve-nocturnal-glycaemic-control-in-women-with-gestational-diabetes-mellitus-8576https://curecurrent.com/trials/mitochondrial-metabolism-and-oxidative-stress-in-function-of-the-physical-exercise-and-nutritional-counseling-in-t2dm-8577https://curecurrent.com/trials/harnessing-human-potential-and-improving-health-span-in-women-and-their-children-8578https://curecurrent.com/trials/multilingual-voice-calls-to-adjust-long-acting-insulin-for-adults-with-type-2-diabetes-and-low-health-literacy-in-pakist-8579https://curecurrent.com/trials/sglt2-inhibition-in-addition-to-lifestyle-intervention-and-risk-for-complications-in-subtypes-of-patients-with-prediabet-8580https://curecurrent.com/trials/effect-of-stress-ball-applied-during-surgical-debridement-dressing-on-pain-distress-and-physiological-parameters-in-pati-8581https://curecurrent.com/trials/assessing-heart-and-brain-metabolism-in-type-ii-diabetes-mellitus-patients-using-carbon-13-mri-8582https://curecurrent.com/trials/efficacy-evaluation-of-turmeric-derived-nanoparticle-hydrogel-for-the-treatment-of-diabetic-foot-ulcer-wounds-8583https://curecurrent.com/trials/intervention-for-high-normal-blood-pressure-in-adults-with-type-2-diabetes-8584https://curecurrent.com/trials/exploration-of-health-literacy-in-diabetes-in-reunion-island-and-france-8585https://curecurrent.com/trials/efficacy-safety-and-treatment-satisfaction-of-once-weekly-tirzepatide-in-obese-type-2-diabetic-patients-8586https://curecurrent.com/trials/holistic-crm-care-vs-standard-of-care-in-a-primary-care-setting-8587https://curecurrent.com/trials/clinical-investigation-of-sorbact-dressings-8588https://curecurrent.com/trials/validation-of-a-biomathematical-model-to-help-identify-the-parameters-of-flexible-insulin-therapy-8589https://curecurrent.com/trials/phase-iii-study-of-ubt251-injection-in-patients-with-type-2-diabetes-with-inadequate-glycemic-control-on-metformin-sulfo-8590https://curecurrent.com/trials/development-of-smart-food-nutraceutical-solutions-dedicated-to-cardiometabolic-disorders-in-ageing-8591https://curecurrent.com/trials/the-impact-of-continuous-glucose-monitoring-on-glucose-variability-and-weight-loss-in-individuals-with-prediabetes-and-o-8592https://curecurrent.com/trials/hair-changes-in-females-with-type-2-diabetes-clinical-and-trichoscopic-examination-8593https://curecurrent.com/trials/study-of-the-prevalence-of-diabetes-and-pre-diabetes-in-r-union-island-8594https://curecurrent.com/trials/effects-of-glp-1-receptor-agonists-on-saliva-and-oral-health-8595https://curecurrent.com/trials/ultrasound-assessment-of-gastri-c-volume-in-pregnant-women-undergoi-ng-electi-ve-cesarean-secti-on-with-and-without-gest-8596https://curecurrent.com/trials/the-coccos-study-a-transition-program-for-young-persons-with-chronic-conditions-8597https://curecurrent.com/trials/screening-for-obstructive-sleep-apnea-in-high-risk-patients-in-a-danish-rural-population-a-pilot-feasibility-study-8598https://curecurrent.com/trials/the-impact-of-cognitive-behavioral-therapy-for-insomnia-cbt-i-on-glycemic-control-in-older-type-2-diabetes-t2d-comorbid-8599https://curecurrent.com/trials/diabetes-prevention-through-genetics-familial-history-and-behavior-change-8600https://curecurrent.com/trials/evaluation-of-the-risk-of-heart-failure-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-mellitus-8601https://curecurrent.com/trials/creation-of-side-to-side-compression-anastomosis-using-the-gt-metabolic-solutions-di-biofragmentable-magnetic-anastomosi-8602https://curecurrent.com/trials/magdi-australia-study-8603https://curecurrent.com/trials/changes-in-person-reported-outcomes-and-behavior-using-the-accu-chek-smartguide-cgm-and-predict-app-8604https://curecurrent.com/trials/exercise-chronotype-and-prediabetes-8605https://curecurrent.com/trials/effect-of-different-carbohydrate-intake-patterns-on-glycemic-control-in-patients-with-type-1-diabetes-8606https://curecurrent.com/trials/adding-sglt2-inhibitors-to-patients-with-type-2-diabetes-8607https://curecurrent.com/trials/effects-of-vlckd-in-metabolic-syndrome-8608https://curecurrent.com/trials/extracellular-vesicle-based-strategy-to-stratify-islets-and-improve-their-fitness-before-transplantation-8609https://curecurrent.com/trials/a-study-to-test-how-insulin-nnc0471-0119-h-works-in-the-body-in-participants-with-type-1-diabetes-when-given-by-an-insul-8610https://curecurrent.com/trials/endoscopic-band-ligation-for-type-2-diabetes-mellitus-endoband-dm-8611https://curecurrent.com/trials/a-three-part-first-in-human-trial-to-assess-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gub-ucn2-in-hea-8612https://curecurrent.com/trials/effect-of-digital-supported-foot-care-education-in-individuals-with-type-2-diabetes-8613https://curecurrent.com/trials/community-physical-exercise-program-in-chronic-disease-8614https://curecurrent.com/trials/hptc-versus-afsm-in-diabetic-foot-ulcers-8615https://curecurrent.com/trials/heart-kidney-diabetes-multidisciplinary-care-models-for-cardiovascular-health-in-patients-with-chronic-kidney-disease-an-8616https://curecurrent.com/trials/role-of-triglyceride-glucose-index-and-inflammatory-biomarkers-as-prognostic-tools-for-progression-of-diabetic-nephropat-8617https://curecurrent.com/trials/optimization-of-basal-insulin-during-ramadan-fasting-in-type-2-diabetic-patients-comparison-between-dar-recommendations-8618https://curecurrent.com/trials/metabolic-and-immunoinflammatory-profiles-in-adults-with-newly-diagnosed-diabetes-8619https://curecurrent.com/trials/evaluating-glucose-control-using-a-next-generation-aid-algorithm-in-individuals-with-t1d-8620https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-enicepatide-in-participants-with-obesity-or-overweight-with-or-without-type-2-diabete-8621https://curecurrent.com/trials/community-based-ehealth-supported-type-2-diabetes-care-by-lay-village-health-workers-in-rural-lesotho-8622https://curecurrent.com/trials/a-twelve-week-pilot-study-evaluating-the-usability-and-preliminary-effects-of-sugarvita-2-0-in-adults-with-type-2-diabet-8623https://curecurrent.com/trials/susceptibility-to-infectious-diseases-in-obesity-8624https://curecurrent.com/trials/fingolimod-for-type-2-diabetes-mellitus-8625https://curecurrent.com/trials/preoperative-optimization-with-tirzepatide-ketogenic-diet-or-standard-care-before-one-anastomosis-gastric-bypass-surgery-8626https://curecurrent.com/trials/phase-2-clinical-study-of-mwn109-tablets-in-participants-with-type-2-diabetes-mellitus-8627https://curecurrent.com/trials/ciclosporin-followed-by-low-dose-il-2-in-patients-with-recently-diagnosed-type-1-diabetes-8628https://curecurrent.com/trials/fib-to-alb-ratio-in-type-2-dkd-8629https://curecurrent.com/trials/integrated-diabetes-and-oral-health-care-in-oman-8630https://curecurrent.com/trials/effectiveness-of-shared-decision-making-sdm-on-patients-with-poor-control-type-2-diabetes-8631https://curecurrent.com/trials/real-world-outcomes-of-tirzepatide-in-pakistani-adults-with-obesity-prediabetes-and-type-2-diabetes-8632https://curecurrent.com/trials/postprandial-effect-of-isocaloric-challenge-meals-enriched-with-indigenous-fruits-and-vegetables-on-glucose-metabolism-i-8633https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-compared-with-standard-of-care-in-adult-participants-with-obesity-and-without-diabetes-8634https://curecurrent.com/trials/icareme-global-registry-multinational-real-world-evidence-in-cardiorenal-and-metabolic-diseases-8635https://curecurrent.com/trials/pmcf-study-of-gx-01s-cgm-in-adults-with-diabetes-8636https://curecurrent.com/trials/impact-of-short-term-intensive-de-escalation-therapy-on-long-term-regimen-simplification-8637https://curecurrent.com/trials/comparing-two-low-carbohydrate-diets-with-a-standard-diet-in-type-2-diabetes-8638https://curecurrent.com/trials/liver-function-test-abnormalities-in-pediatric-type-1-diabetes-8639https://curecurrent.com/trials/phase-1-clinical-study-of-mwn105-injection-in-participants-with-overweight-or-obesity-8640https://curecurrent.com/trials/lifestyle-changes-mushroom-supplementation-and-bupropion-to-reduce-adiposity-and-cardiometabolic-risk-8641https://curecurrent.com/trials/comparing-glycemic-outcomes-of-carbohydrate-counting-vs-fixed-mealtime-insulin-dosing-in-hospitalized-patients-with-hype-8642https://curecurrent.com/trials/effect-of-continuous-glucose-monitoring-system-on-glycemic-control-in-non-insulin-treated-elderly-people-with-type-2-dia-8643https://curecurrent.com/trials/effect-of-individualized-nursing-care-on-diabetes-self-management-8644https://curecurrent.com/trials/semaglutide-for-smoking-cessation-in-patients-with-diabetes-8645https://curecurrent.com/trials/reexamining-her-cardiovascular-risk-ottawa-women-s-longitudinal-cohort-study-8646https://curecurrent.com/trials/clinical-efficacy-of-modified-simiao-yongan-decoction-and-endovascular-therapy-for-diabetic-foot-ulcers-8647https://curecurrent.com/trials/genetically-informed-screening-for-early-stage-type-1-diabetes-8648https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-and-efficacy-of-rgb-5088-in-patients-with-type-2-diabetes-mellitus-8649https://curecurrent.com/trials/characteristics-of-nafld-among-type-2-diabetes-patients-8650https://curecurrent.com/trials/feasibility-and-acceptability-of-non-weight-bearing-physical-activity-for-people-with-diabetic-foot-ulceration-8651https://curecurrent.com/trials/impact-of-pharmacogenetic-guided-treatment-on-type-2-diabetes-8652https://curecurrent.com/trials/oral-verapamil-among-newly-diagnosed-children-and-adolescents-with-type-1-diabetes-8653https://curecurrent.com/trials/safety-and-efficacy-of-the-combination-therapy-of-fucoidan-fucoxanthin-l-carnitine-in-patients-with-diabetic-nephropathy-8654https://curecurrent.com/trials/effects-of-transcutaneous-photobiomodulation-on-diabetic-foot-ulcers-8655https://curecurrent.com/trials/efficacy-and-safety-of-syh2069-injection-in-obese-participants-without-diabetes-8656https://curecurrent.com/trials/llm-comanage-large-language-model-enabled-co-management-of-hypertension-diabetes-and-dyslipidemia-8657https://curecurrent.com/trials/goal-directed-therapy-to-reduce-kidney-and-cardiovascular-risk-in-diabetic-kidney-disease-gold-standard-8658https://curecurrent.com/trials/monitoring-of-the-sympathetic-vagal-balance-through-multiparametric-analysis-of-heart-rate-variability-hrv-8659https://curecurrent.com/trials/phase-1-clinical-study-of-mwn105-injection-in-healthy-chinese-volunteers-8660https://curecurrent.com/trials/early-detection-of-type-1-diabetes-8661https://curecurrent.com/trials/comparison-of-metformin-versus-glyburide-for-blood-sugar-control-in-women-with-gestational-diabetes-8662https://curecurrent.com/trials/ultrasonographic-evaluation-of-talar-cartilage-thickness-in-patients-with-diabetic-polyneuropathy-8663https://curecurrent.com/trials/postprandial-glucose-kinetics-after-carbohydrate-restriction-8664https://curecurrent.com/trials/digital-self-management-education-and-support-for-young-adults-with-type-2-diabetes-dsmesyat2dm-8665https://curecurrent.com/trials/systemic-biochemical-signature-and-functional-quality-index-of-calcaneal-bone-marrow-aspirate-in-adults-undergoing-foot-8666https://curecurrent.com/trials/polycystic-ovary-syndrome-in-type-1-diabetes-8667https://curecurrent.com/trials/a-study-comparing-an-investigational-wound-gel-with-standard-treatment-for-mild-to-moderate-diabetic-foot-ulcers-8668https://curecurrent.com/trials/effectiveness-of-a-rehabilitation-treatment-with-nordic-walking-in-obese-or-overweight-patients-8669https://curecurrent.com/trials/a-study-to-evaluate-different-administration-conditions-and-the-food-effect-of-mwn109-tablets-in-chinese-participants-8670https://curecurrent.com/trials/information-follow-up-and-early-diagnosis-of-children-at-risk-for-type-1-diabetes-8671https://curecurrent.com/trials/clinical-oncologic-and-metabolic-effects-of-pancreatic-mass-loss-after-pancreatectomy-in-non-diabetic-patients-8672https://curecurrent.com/trials/montbretin-clinical-trial-in-healthy-volunteers-and-type-2-diabetics-8673https://curecurrent.com/trials/making-diabetes-care-fit-for-young-adults-living-with-type-1-diabetes-observations-reflections-and-expert-opinions-8674https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-or-semaglutide-in-overweight-obese-patients-with-type-1-diabetes-8675https://curecurrent.com/trials/central-venous-vs-arterial-blood-gas-and-co2-gap-in-critically-ill-patients-with-and-without-diabetes-8676https://curecurrent.com/trials/a-study-investigating-the-safety-absorption-elimination-and-the-effect-on-the-immune-system-of-aci-19764-in-healthy-part-8677https://curecurrent.com/trials/correlation-between-dietary-patterns-anthropometric-profiles-genetic-profiles-and-biomarker-levels-to-diabetes-8678https://curecurrent.com/trials/efficacy-of-topical-lidocaine-gel-vs-oral-duloxetine-for-painful-diabetic-peripheral-neuropathy-8679https://curecurrent.com/trials/mazdutide-in-type-2-diabetes-with-early-stage-cognitive-impairment-light-cog-study-8680https://curecurrent.com/trials/study-evaluating-the-safety-and-feasibility-of-endoscopic-duodenal-injections-of-autologous-mesenchymal-stem-cells-8681https://curecurrent.com/trials/pasteurised-donor-human-milk-supplementation-for-term-babies-8682https://curecurrent.com/trials/free-fatty-acid-effects-in-type-2-diabetes-8683https://curecurrent.com/trials/the-effect-of-body-weight-on-physical-activity-level-functional-capacity-balance-and-quality-of-life-in-individuals-with-8684https://curecurrent.com/trials/continuous-glucose-monitoring-for-in-hospital-management-of-type-2-diabetes-8685https://curecurrent.com/trials/a-study-of-syh2069-injection-in-participants-with-t2dm-not-controlled-with-diet-exercise-alone-or-metformin-8686https://curecurrent.com/trials/comparing-a-healthy-beef-centric-diet-to-a-healthy-u-s-style-diet-on-metabolic-health-outcomes-in-pre-diabetic-adults-8687https://curecurrent.com/trials/predict-dm-community-pharmacy-based-point-of-care-testing-for-undiagnosed-t2dm-8688https://curecurrent.com/trials/effect-of-fish-intake-on-metabolic-health-in-a-diabetic-south-asian-population-fish-meal-8689https://curecurrent.com/trials/diabetic-nephropathy-glycemic-control-and-pseudophakic-macular-edema-after-cataract-surgery-8690https://curecurrent.com/trials/group-care-for-hypertension-and-diabetes-management-in-nepal-8691https://curecurrent.com/trials/developing-and-testing-a-model-to-identify-preventive-vision-loss-among-older-patients-in-general-practice-8692https://curecurrent.com/trials/glycemic-velocity-and-early-retinal-microvascular-change-with-glp-1ra-versus-sglt2i-initiation-in-type-2-diabetes-glide-8693https://curecurrent.com/trials/local-and-systemic-inflammatory-bone-alterations-related-to-dental-implant-survival-8694https://curecurrent.com/trials/assessing-the-effects-of-a-buckwheat-beverage-on-postprandial-glucose-metabolism-on-healthy-and-t2d-individuals-8695https://curecurrent.com/trials/paths-t2d-a-recall-by-genotype-study-of-physiologic-and-pharmacologic-responses-8696https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-da-302168s-tablets-in-subjects-with-type-2-diabetes-8697https://curecurrent.com/trials/effects-of-a-researcher-designed-diabetes-self-management-app-on-self-management-obstacles-self-efficacy-and-physiologic-8698https://curecurrent.com/trials/effectiveness-of-a-multimodal-intervention-on-function-in-older-frail-people-with-diabetes-in-latinamerican-8699https://curecurrent.com/trials/telehealth-educational-intervention-for-adults-with-type-2-diabetes-in-oman-8700https://curecurrent.com/trials/a-clinical-trial-evaluating-tqf3250-capsules-in-patients-with-type-2-diabetes-mellitus-and-overweight-obesity-8701https://curecurrent.com/trials/long-term-health-and-economic-effects-of-an-individualized-lifestyle-intervention-li-pad-extended-8702https://curecurrent.com/trials/precision-diabetes-education-guided-by-diabetes-complication-risk-assessment-8703https://curecurrent.com/trials/continuous-glucose-monitoring-and-clinical-outcomes-in-diabetes-on-peritoneal-dialysis-8704https://curecurrent.com/trials/mindfulness-based-cognitive-behavioral-program-for-people-with-diabetes-mellitus-8705https://curecurrent.com/trials/cfmsc-therapy-for-diabetes-8706https://curecurrent.com/trials/effects-of-aerobic-exercise-on-shoulder-pain-disability-and-ultrasonographic-outcomes-in-patients-with-type-2-diabetes-m-8707https://curecurrent.com/trials/general-use-results-surveillance-with-awiqli-in-patients-with-diabetes-mellitus-8708https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-atb-1011-atb-1012-co-administration-for-essential-hypertension-and-type-ii-diabetes-8709https://curecurrent.com/trials/long-term-effects-of-avocado-consumption-on-health-in-pre-diabetic-individuals-8710https://curecurrent.com/trials/correlation-of-anti-gravity-muscle-strength-with-glycemic-control-duration-of-disease-and-neuropathy-severity-in-type-2-8711https://curecurrent.com/trials/integrating-educational-videos-into-skills-based-nutrition-programs-to-reduce-type-2-diabetes-risk-in-peel-8712https://curecurrent.com/trials/effects-of-self-selected-music-on-self-injection-fear-blood-glucose-testing-fear-and-pain-8713https://curecurrent.com/trials/effectiveness-of-combining-patient-follow-up-with-an-educational-intervention-on-self-management-skills-of-type-2-diabet-8714https://curecurrent.com/trials/diet-impact-on-hepatic-transcriptomics-and-lipidomics-in-pre-diabetes-8715https://curecurrent.com/trials/early-pregnancy-glucose-profiles-in-women-with-and-without-gdm-risk-factors-early-glow-8716https://curecurrent.com/trials/an-exploratory-clinical-study-evaluating-allogeneic-ipsc-derived-pancreatic-islet-cells-crg-002-for-the-treatment-of-dia-8717https://curecurrent.com/trials/pilot-rct-of-pipe-ai-for-prediabetes-and-diabetes-self-management-8718https://curecurrent.com/trials/controlled-trial-to-evaluate-the-safety-and-efficacy-of-cywc628-human-dermal-fibroblast-spheroids-for-the-treatment-of-r-8719https://curecurrent.com/trials/metformin-in-elderly-patients-with-type-2-diabetes-and-muscle-strength-muscle-mass-and-physical-function-positive-or-neg-8720https://curecurrent.com/trials/performance-and-safety-of-mepilex-up-in-leg-and-foot-ulcers-and-skin-tears-8721https://curecurrent.com/trials/high-resolution-imaging-oct-study-8722https://curecurrent.com/trials/safety-and-efficacy-evaluation-of-4th-generation-safety-engineered-car-t-cells-targeting-sarcomas-8723https://curecurrent.com/trials/real-world-study-of-patients-with-type-1-diabetes-treated-with-teplizumab-as-part-of-managed-access-programs-maps-8724https://curecurrent.com/trials/roxadustat-versus-erythropoietin-for-anaemia-treatment-in-diabetic-nephropathy-8725https://curecurrent.com/trials/effect-of-rosmarinus-officinalis-extract-on-oxidative-stress-and-inflammatory-biomarkers-in-patients-with-type-2-diabete-8726https://curecurrent.com/trials/study-on-improving-blood-glucose-homeostasis-with-dorzagliatin-tablets-in-the-treatment-of-type-2-diabetes-mellitus-pati-8727https://curecurrent.com/trials/the-effect-of-sea-buckthorn-extract-in-patients-with-type-1-diabetes-8728https://curecurrent.com/trials/transforming-primary-care-payment-in-hawaii-8729https://curecurrent.com/trials/diabetes-and-permanent-disabilities-8730https://curecurrent.com/trials/a-trial-to-learn-how-safe-azd9550-monotherapy-and-combined-with-azd6234-is-in-people-with-or-without-type-2-diabetes-who-8731https://curecurrent.com/trials/the-effect-of-animated-movies-and-storybooks-on-fear-and-anxiety-levels-in-children-with-type-1-diabetes-8732https://curecurrent.com/trials/exploring-skin-barrier-function-recurrence-of-diabetes-device-related-contact-dermatitis-and-evaluation-of-hydrocolloid-8733https://curecurrent.com/trials/the-experiment-of-noiiglutide-injection-in-type-2-diabetes-patients-8734https://curecurrent.com/trials/omnipod-5-implementation-in-belgian-paediatric-diabetes-care-8735https://curecurrent.com/trials/clinical-evaluation-of-salivary-1-5-anhydroglucitol-in-diabetes-8736https://curecurrent.com/trials/experience-with-the-use-of-continuous-glucose-monitoring-cgm-devices-in-people-with-type-2-diabetes-mellitus-8737https://curecurrent.com/trials/e-health-literacy-intervention-for-bangladeshi-migrants-with-type-2-diabetes-in-italy-8738https://curecurrent.com/trials/influence-of-continuous-glucose-monitoring-on-quality-of-life-in-people-with-type-2-diabetes-mellitus-8739https://curecurrent.com/trials/comparative-study-of-the-postprandial-glycemic-profile-after-consumption-of-a-high-fat-meal-pizza-between-the-open-loop-8740https://curecurrent.com/trials/improvement-through-movement-balance-control-and-somatosensory-function-in-people-with-diabetes-mellitus-type-2-8741https://curecurrent.com/trials/development-and-pilot-implementation-of-a-shared-decision-making-intervention-for-type-2-diabetes-using-the-ottawa-frame-8742https://curecurrent.com/trials/the-proactive-study-integrating-a-proactive-and-palliative-care-approach-to-diabetic-ulcer-care-8743https://curecurrent.com/trials/non-surgical-periodontal-therapy-and-kidney-outcomes-in-type-2-diabetes-mellitus-8744https://curecurrent.com/trials/innodia-family-friends-early-stage-t1d-detection-protocol-8745https://curecurrent.com/trials/small-cell-lung-carcinoma-trial-with-nivolumab-and-ipilimumab-in-limited-disease-8746https://curecurrent.com/trials/using-healthcare-financing-and-digital-technology-to-improve-hypertension-prevention-and-control-in-tanzania-8747https://curecurrent.com/trials/obesial-a-prospective-interventional-real-world-study-of-a-multidisciplinary-obesity-management-programme-8748https://curecurrent.com/trials/digital-care-for-holistic-health-in-older-adults-with-diabetes-and-multimorbidity-8749https://curecurrent.com/trials/vascular-regenerative-cell-exhaustion-in-adults-with-peripheral-artery-disease-pad-vrce-8750https://curecurrent.com/trials/an-innovative-proprioceptive-instrument-for-upper-extremities-8751https://curecurrent.com/trials/expanded-access-for-metreleptin-for-the-treatment-of-diabetes-mellitus-and-or-hypertriglyceridemia-associated-with-lipod-8752https://curecurrent.com/trials/ceeec-ii-a-12-week-physical-and-cognitive-enrichment-extension-study-in-older-stroke-survivors-with-multimorbidity-8753https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-adult-participants-in-india-with-either-type-2-diabetes-mellitus-or-obesity-8754https://curecurrent.com/trials/legume-flour-particle-size-and-metabolic-responses-to-bread-8755https://curecurrent.com/trials/cgm-use-in-adults-with-type-2-diabetes-on-basal-insulin-8756https://curecurrent.com/trials/effects-of-telerehabilitative-aerobic-and-relaxation-exercises-patients-with-type-2-diabetes-with-and-without-covid-19-8757https://curecurrent.com/trials/phase-1-1b-study-of-tlc-6740-in-healthy-subjects-and-subjects-with-obesity-with-or-without-diabetes-8758https://curecurrent.com/trials/metformin-dapagliflozin-effects-on-igf-1-in-male-t2dm-with-masld-8759https://curecurrent.com/trials/effects-of-bedtime-snack-composition-on-overnight-glucose-in-children-and-adolescents-with-type-1-diabetes-8760https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-fasting-duration-and-dulaglutide-ly2189265-withholding-on-gastric-retention-in-partici-8761https://curecurrent.com/trials/evaluating-the-effect-of-adipose-tissue-processed-with-the-syntrfuge-system-in-the-healing-of-diabetic-foot-ulcers-8762https://curecurrent.com/trials/effectiveness-and-utility-of-telemonitoring-in-improving-the-glycaemic-control-of-diabetes-mellitus-tunisian-patients-8763https://curecurrent.com/trials/european-survey-of-cardiovascular-disease-prevention-diabetes-and-chronic-kidney-disease-euroaspire-vi-8764https://curecurrent.com/trials/serum-neurofilament-light-chain-levels-and-neuropathy-severity-in-diabetic-polyneuropathy-8765https://curecurrent.com/trials/ultrasonic-enhancement-delivery-of-phosphodiesterase-inhibitors-nanoparticles-for-diabetic-management-of-the-foot-8766https://curecurrent.com/trials/effects-of-otago-exercise-versus-multisensory-integration-training-on-balance-and-gait-in-elderly-with-diabetes-8767https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-semaglutide-depot-in-subjects-with-type-2-diabetes-mellitus-8768https://curecurrent.com/trials/encrt-103-hpi-evaluation-of-an-immune-protected-encrt-103-hpi-containing-primary-human-islets-in-adults-with-type-1-diab-8769https://curecurrent.com/trials/smartphone-screening-for-eye-diseases-8770https://curecurrent.com/trials/quartet-dkd-quadruple-therapy-for-type-2-diabetic-nephropathy-8771https://curecurrent.com/trials/huangqi-gegen-decoction-for-endothelial-function-in-type-2-diabetes-at-very-high-ascvd-risk-8772https://curecurrent.com/trials/exercise-and-diabetes-interventions-to-improve-brain-health-in-older-adults-with-type-2-diabetes-8773https://curecurrent.com/trials/time-restricted-eating-and-high-intensity-interval-training-after-gestational-diabetes-8774https://curecurrent.com/trials/diabetes-specific-formulas-on-nutritional-outcomes-in-individuals-with-diabetes-who-require-nutritional-support-8775https://curecurrent.com/trials/are-there-any-clinical-benefits-to-screening-for-late-onset-gestational-diabetes-mellitus-8776https://curecurrent.com/trials/early-detection-of-type-1-diabetes-in-first-degree-relatives-of-type-1-diabetes-patients-detect-t1d-gulf-8777https://curecurrent.com/trials/systemic-immune-inflammation-index-and-platelet-parameters-in-diabetic-kidney-disease-8778https://curecurrent.com/trials/prospective-cohort-study-of-4-837-post-myocardial-infarction-patients-alpha-omega-cohort-8779https://curecurrent.com/trials/cardiovascular-kidney-metabolic-ckm-guided-therapy-for-patients-after-acute-coronary-syndrome-8780https://curecurrent.com/trials/oral-galactose-as-a-substrate-for-post-exercise-skeletal-muscle-glycogen-repletion-in-individuals-with-type-1-diabetes-8781https://curecurrent.com/trials/the-effect-of-empagliflozin-and-metformin-on-oxidative-capacity-and-microvascular-reactivity-of-skeletal-muscle-in-patie-8782https://curecurrent.com/trials/glycaemic-outcomes-with-whey-protein-in-ageing-8783https://curecurrent.com/trials/perioperative-meditation-music-intervention-in-patients-with-type-2-diabetes-undergoing-elective-surgery-8784https://curecurrent.com/trials/connected-care-for-type-2-diabetes-self-management-8785https://curecurrent.com/trials/study-evaluating-the-metabolic-effects-of-pulsendo-therapy-in-adults-with-type-2-diabetes-8786https://curecurrent.com/trials/peripheral-magnetic-stimulation-with-balance-training-to-decrease-fall-risks-in-diabetic-polyneuropathy-8787https://curecurrent.com/trials/continuous-glucose-monitoring-cgm-after-kidney-transplantation-8788https://curecurrent.com/trials/validation-of-the-snouda-metabolic-score-for-phenotyping-and-guiding-reversal-in-type-2-diabetes-8789https://curecurrent.com/trials/cardioprotective-effects-of-sglt2-inhibitors-and-glp-1-receptor-agonists-in-korean-patients-with-type-2-diabetes-8790https://curecurrent.com/trials/integrated-oral-care-intervention-for-xerostomia-in-diabetes-patients-8791https://curecurrent.com/trials/rowing-and-cycling-reduce-inflammation-in-early-stage-type-2-diabetes-8792https://curecurrent.com/trials/cardiac-arrhythmia-in-patients-with-end-stage-renal-disease-8793https://curecurrent.com/trials/screening-for-change-early-risk-detection-and-integrated-prevention-for-diabetes-and-cardiovascular-diseases-in-the-marc-8794https://curecurrent.com/trials/mazdutide-for-remission-of-type-2-diabetes-multicentre-double-blind-randomised-placebo-controlled-trial-8795https://curecurrent.com/trials/pre-diagnosis-glp-1-receptor-agonist-use-and-post-cancer-mortality-in-adults-with-obesity-and-type-2-diabetes-8796https://curecurrent.com/trials/efficacy-and-safety-of-hebenrun-in-patients-with-type-2-diabetes-8797https://curecurrent.com/trials/implementation-of-networked-continuous-glucose-monitoring-with-telemetry-within-the-intensive-care-unit-icu-telecgm-8798https://curecurrent.com/trials/prodiap-patient-reported-outcomes-in-general-practice-among-people-with-type-2-diabetes-8799https://curecurrent.com/trials/effectiveness-of-electrical-stimulation-evaluated-using-digital-and-sensorimotor-outcomes-in-patients-with-sensorimotor-8800https://curecurrent.com/trials/continuous-monitoring-of-glycemic-variability-to-predict-dys-and-hyperglycemia-in-asymptomatic-type-1-diabetes-8801https://curecurrent.com/trials/the-effect-of-l-carnitine-on-wound-healing-in-patients-with-diabetic-foot-ulcer-8802https://curecurrent.com/trials/testing-a-diabetes-care-program-in-rural-and-low-income-clinics-8803https://curecurrent.com/trials/placental-weight-in-infants-of-gestational-diabetic-mothers-8804https://curecurrent.com/trials/a-study-of-macupatide-ly3532226-in-participants-with-obesity-or-overweight-without-type-2-diabetes-8805https://curecurrent.com/trials/lactoferrin-supplementation-in-diabetic-nephropathy-8806https://curecurrent.com/trials/prospective-evaluation-of-stapled-intact-duodenum-bipartition-with-sleeve-gastrectomy-sibs-8807https://curecurrent.com/trials/diabetic-foot-ulcers-shorter-treatment-period-using-custom-felt-relief-8808https://curecurrent.com/trials/the-role-of-the-adrenergic-system-in-hypoglycaemia-induced-inflammatory-response-in-people-with-type-1-diabetes-and-peop-8809https://curecurrent.com/trials/a-research-study-to-see-if-two-different-formulations-of-oral-semaglutide-are-equally-safe-and-effective-in-reducing-the-8810https://curecurrent.com/trials/gamification-intervertion-in-children-with-type-1-diabetes-8811https://curecurrent.com/trials/effects-of-bfrt-on-glycemic-control-nerve-conduction-functional-outcomes-and-qol-in-individuals-with-type-2-diabetes-8812https://curecurrent.com/trials/snapdandcgmintype2dm-8813https://curecurrent.com/trials/continuous-glucose-monitoring-in-high-risk-children-and-youth-with-type-1-diabetes-in-the-dominican-republic-8814https://curecurrent.com/trials/couple-coordinated-lifestyle-intervention-for-women-with-a-history-of-gestational-diabetes-mellitus-8815https://curecurrent.com/trials/impact-of-online-medical-misinformation-8816https://curecurrent.com/trials/application-of-growth-factors-derived-from-platelets-to-accelerate-healing-and-reduce-post-extraction-complications-in-d-8817https://curecurrent.com/trials/effect-of-diabetic-medications-on-bone-metabolism-8818https://curecurrent.com/trials/sema-cardiodiab-hungary-a-research-study-to-understand-the-effects-of-oral-semaglutide-on-blood-sugar-levels-weight-and-8819https://curecurrent.com/trials/the-postprandial-hypo-avoid-study-8820https://curecurrent.com/trials/a-study-to-see-the-effect-of-nnc0194-0499-alone-or-in-combination-with-semaglutide-on-blood-sugar-control-in-people-livi-8821https://curecurrent.com/trials/pain-neuroscience-education-and-graded-motor-imagery-combined-with-conventional-physiotherapy-on-diabetic-adhesive-capsu-8822https://curecurrent.com/trials/effect-of-csir-developed-high-protein-low-glycaemic-index-rice-on-glycaemic-response-in-individuals-with-prediabetes-8823https://curecurrent.com/trials/comparative-effects-of-aspirin-metformin-and-sglt2-inhibitors-on-liver-enzymes-lipid-profile-and-fibroscan-findings-in-n-8824https://curecurrent.com/trials/residual-gastric-volume-measured-by-ultrasound-in-diabetic-surgical-population-versus-non-diabetic-surgical-population-8825https://curecurrent.com/trials/cgm-based-glycemic-analysis-after-esi-8826https://curecurrent.com/trials/metformin-effects-according-to-slc16a11-carrier-status-8827https://curecurrent.com/trials/research-on-gut-microbiota-and-metabolomics-in-diabetic-kidney-disease-8828https://curecurrent.com/trials/foot-care-and-exercises-implementation-for-people-with-diabetes-in-primary-care-8829https://curecurrent.com/trials/effect-of-nicorandil-in-type-2-diabetic-obese-patients-8830https://curecurrent.com/trials/early-screening-of-pancreatic-lesions-development-of-new-imaging-tools-8831https://curecurrent.com/trials/determining-the-effect-of-food-ordering-on-blood-glucose-in-gestational-diabetes-mellitus-defi-gdm-8832https://curecurrent.com/trials/automated-insulin-delivery-versus-usual-insulin-treatment-modality-before-and-during-pregnancy-in-women-with-type-1-diab-8833https://curecurrent.com/trials/nanotechnological-silver-coated-dressing-in-diabetic-foot-ulcers-8834https://curecurrent.com/trials/study-of-htd4010-in-healthy-volunteers-8835https://curecurrent.com/trials/evaluation-of-a-mobile-application-designed-to-support-type-1-diabetic-patients-in-adjusting-their-insulin-doses-8836https://curecurrent.com/trials/clinical-and-radiographic-evaluation-of-subgingival-1-metformin-gel-versus-0-05-zoledronate-gel-as-an-adjunct-to-minst-o-8837https://curecurrent.com/trials/efficacy-and-safety-of-berberine-ursodeoxycholate-htd1801-in-patients-with-type-2-diabetes-inadequately-controlled-with-8838https://curecurrent.com/trials/no-meal-announcement-in-automated-insulin-delivery-open-source-and-commercial-systems-8839https://curecurrent.com/trials/a-research-study-to-see-how-well-weekly-insulin-icodec-maintains-blood-sugar-levels-compared-to-daily-basal-insulins-in-8840https://curecurrent.com/trials/pilot-rct-of-a-chinese-medicine-diabetes-education-programme-8841https://curecurrent.com/trials/digital-dietary-intervention-for-patients-receiving-glp-1-receptor-agonist-therapy-8842https://curecurrent.com/trials/brain-heart-axis-in-type-2-diabetes-mellitus-8843https://curecurrent.com/trials/a-clinical-trial-comparing-the-efficacy-and-safety-of-exubera-and-lantus-8844https://curecurrent.com/trials/plasma-oxytocin-response-to-oral-estrogens-in-healthy-controls-and-avp-deficiency-8845https://curecurrent.com/trials/the-therapeutic-effects-of-ceylon-cinnamon-supplementation-and-a-self-efficacy-educational-program-on-glycemic-control-l-8846https://curecurrent.com/trials/validation-of-the-artificial-intelligence-subsystem-of-the-ddart-medical-device-for-the-automated-detection-of-lesions-c-8847https://curecurrent.com/trials/effect-of-dairy-products-on-insulin-resistance-8848https://curecurrent.com/trials/efficacy-of-noshintrial-in-diabetic-patients-8849https://curecurrent.com/trials/the-effect-of-bitter-orange-citrus-aurantium-oil-aromatherapy-on-sleep-quality-and-fatigue-levels-8850https://curecurrent.com/trials/screening-and-characterization-of-hearing-disorders-in-diabetic-persons-8851https://curecurrent.com/trials/spark-a-digital-platform-to-improve-self-management-of-gestational-diabetes-8852https://curecurrent.com/trials/ai-screening-for-diabetic-retinopathy-8853https://curecurrent.com/trials/continuous-glucose-monitoring-glycemic-characterization-during-pregnancy-8854https://curecurrent.com/trials/nmes-exercise-and-glycemic-control-in-older-adults-with-type-2-diabetes-8855https://curecurrent.com/trials/effect-of-an-intervention-with-apple-cider-vinegar-on-glycemic-variability-and-lipid-profile-in-patients-with-type-2-dia-8856https://curecurrent.com/trials/calorie-restricted-dietary-intervention-in-type-2-diabetes-patients-with-obesity-for-remission-8857https://curecurrent.com/trials/domestication-and-implementation-of-the-pen-plus-clinical-model-in-the-zambian-health-system-8858https://curecurrent.com/trials/peer-supported-diabetes-self-care-intervention-to-improve-health-related-quality-of-life-hrqol-and-diabetes-management-8859https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-extending-the-passerelle-system-for-prescribing-adapted-physical-activity-to-patients-8860https://curecurrent.com/trials/surgical-treatment-for-obesity-related-disease-and-onco-metabolic-surgery-8861https://curecurrent.com/trials/effect-of-cgm-on-glucose-control-in-non-insulin-treated-patients-with-type-2-diabetes-mellitus-8862https://curecurrent.com/trials/clinical-study-to-assess-the-safety-efficacy-and-in-use-tolerability-of-herbal-based-sugar-support-effervescent-tablets-8863https://curecurrent.com/trials/integrated-hyperglycaemia-incentivised-postnatal-surveillance-study-i-hips-8864https://curecurrent.com/trials/circulating-vascular-regenerative-cell-exhaustion-in-individuals-without-type-2-diabetes-who-are-of-south-asian-or-europ-8865https://curecurrent.com/trials/del-1-and-thromboxane-a2-in-diabetic-nephropathy-patients-8866https://curecurrent.com/trials/effectiveness-of-a-low-calorie-diet-combined-with-intensive-lifestyle-intervention-using-integrated-personalized-diabete-8867https://curecurrent.com/trials/examining-the-effect-of-mobile-application-on-insulin-use-perception-and-self-management-8868https://curecurrent.com/trials/trial-to-evaluate-efficacy-safety-of-revita-dmr-treatment-paradigm-1-and-retreatment-in-type-2-diabetes-patients-8869https://curecurrent.com/trials/assess-the-possibility-of-diagnosing-diabetes-and-rediabetes-following-oral-induced-hyperglycemia-in-patients-with-dunni-8870https://curecurrent.com/trials/evaluation-of-the-effects-of-gluten-free-diet-on-clinical-symptoms-and-glycemic-index-in-type-2-diabetic-patients-with-n-8871https://curecurrent.com/trials/a-trial-to-evaluate-safety-feasibility-and-efficacy-of-endoscopic-duodenal-pef-therapy-8872https://curecurrent.com/trials/light-mci-trial-glp-1-agonist-sglt2-inhibitor-and-dpp-4-inhibitor-for-mci-remission-in-type-2-diabetes-8873https://curecurrent.com/trials/the-role-of-progesterone-membrane-receptors-in-the-development-of-gestational-diabetes-mellitus-8874https://curecurrent.com/trials/study-of-metabolic-dysfunction-associated-steatotic-liver-disease-masld-in-adults-with-type-1-diabetes-8875https://curecurrent.com/trials/copeptin-and-acute-coronary-syndrome-without-st-segment-elevation-8876https://curecurrent.com/trials/isometric-strengthening-exercises-versus-tens-in-diabetic-population-8877https://curecurrent.com/trials/effect-of-a-coordinated-primary-care-based-mdt-model-on-the-treatment-of-hard-to-heal-ulcers-8878https://curecurrent.com/trials/assessment-of-retinal-microvascular-changes-by-oct-angiography-in-diabetic-retinopathy-8879https://curecurrent.com/trials/impact-of-high-oleic-palm-oil-consumption-on-cardiovascular-biomarkers-in-adults-in-bogot-8880https://curecurrent.com/trials/effects-of-autonomic-nervous-system-modulation-by-heart-rate-variability-biofeedback-training-with-resonant-frequency-br-8881https://curecurrent.com/trials/assessing-the-effectiveness-of-large-language-model-llm-enabled-nurse-treatment-planning-in-2-indian-districts-8882https://curecurrent.com/trials/insulin-icodec-initiation-strategies-and-day-4-supplemental-dosing-in-type-2-diabetes-8883https://curecurrent.com/trials/dia-conn-p8-smart-insulin-pen-study-in-diabetes-patients-8884https://curecurrent.com/trials/cognitive-intervention-for-cognitive-impairment-8885https://curecurrent.com/trials/ogtt-at-home-using-cgm-vs-at-the-clinic-8886https://curecurrent.com/trials/coq10-effects-on-mdm-liver-fat-via-fibrotouchi-8887https://curecurrent.com/trials/ultrasound-enhanced-propolis-therapy-for-healing-diabetic-foot-wounds-8888https://curecurrent.com/trials/the-bright-study-device-name-halo-system-8889https://curecurrent.com/trials/injectheal-investigation-of-chronic-wound-exudate-and-biofilm-8890https://curecurrent.com/trials/optimal-blood-pressure-for-the-prevention-of-major-vascular-events-in-patients-with-diabetes-mellitus-optimal-diabetes-8891https://curecurrent.com/trials/efficacy-of-negative-pressure-wound-therapy-versus-conventional-moist-dressings-on-diabetic-foot-ulcer-healing-trajector-8892https://curecurrent.com/trials/menopausal-hormone-therapy-glp-1-agonists-and-glucose-and-energy-homeostasis-in-postmenopausal-women-with-diabetes-8893https://curecurrent.com/trials/a-study-of-bgm0504-in-early-t2dm-with-obesity-8894https://curecurrent.com/trials/digital-intervention-promoting-physical-activity-among-obese-people-dippao-8895https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-volrustomig-casdatifan-vs-nivolumab-ipilimumab-as-1l-treatment-for-adv-8896https://curecurrent.com/trials/small-steps-for-big-changes-healthy-cities-implementation-science-8897https://curecurrent.com/trials/omnipod-5-a-french-prospective-multicentric-study-in-real-world-optimal-b-8898https://curecurrent.com/trials/french-prospective-multicentric-study-in-real-world-8899https://curecurrent.com/trials/precision-lifestyle-medicine-program-for-ifhas-participants-8900https://curecurrent.com/trials/a-phase-2-study-of-berberine-ursodeoxycholate-htd1801-in-patients-with-type-2-diabetes-inadequately-controlled-with-diet-8901https://curecurrent.com/trials/health-for-hungary-h4h-longitudinal-collection-of-blood-samples-and-corresponding-data-8902https://curecurrent.com/trials/co-designing-enhanced-models-of-care-for-first-nations-children-at-risk-for-childhood-onset-type-2-diabetes-8903https://curecurrent.com/trials/effects-of-berberine-ursodeoxycholate-htd1801-versus-dapagliflozin-in-patients-with-type-2-diabetes-inadequately-control-8904https://curecurrent.com/trials/vacuum-compression-therapy-for-chronic-lower-limb-ulcers-8905https://curecurrent.com/trials/efficacy-and-safety-of-berberine-ursodeoxycholate-htd1801-in-patients-with-type-2-diabetes-8906https://curecurrent.com/trials/investigating-vascular-properties-of-hemi-and-spg-signals-in-individuals-with-or-at-risk-for-chronic-kidney-disease-8907https://curecurrent.com/trials/evaluating-the-occurrence-of-dka-in-people-with-type-i-diabetes-8908https://curecurrent.com/trials/effectiveness-of-low-calorie-mind-hk-diet-and-very-low-calorie-diet-on-glycemic-control-and-cardiovascular-outcomes-in-a-8909https://curecurrent.com/trials/mobile-based-obstetric-monitoring-for-pregnancies-complicated-by-hypertension-and-or-diabetes-mom-hd-8910https://curecurrent.com/trials/gb268-monotherapy-or-combination-therapy-for-locally-advanced-metastatic-breast-cancer-phase-ib-8911https://curecurrent.com/trials/blood-based-sev-proteins-for-early-detection-of-2-diabetes-8912https://curecurrent.com/trials/relationship-between-red-cell-distribution-width-rdw-and-hba1c-in-patients-with-type-2-diabetes-mellitus-after-glycemic-8913https://curecurrent.com/trials/societal-burden-associated-with-type-1-diabetes-in-canada-8914https://curecurrent.com/trials/a-study-of-hrs9531-versus-semaglutide-once-weekly-as-add-on-therapy-to-metformin-monotherapy-or-in-combination-with-sglt-8915https://curecurrent.com/trials/the-impact-of-diabetes-remission-on-aging-8916https://curecurrent.com/trials/a-study-of-syh2069-injection-in-healthy-participants-8917https://curecurrent.com/trials/therapeutic-synergy-of-probiotic-augmented-conventional-antidiabetic-pharmacotherapy-in-gestational-diabetes-mellitus-8918https://curecurrent.com/trials/fecal-microbiota-transplantation-for-type-2-diabetes-mellitus-and-hashimoto-s-thyroiditis-8919https://curecurrent.com/trials/assessing-the-effectiveness-of-continuous-glucose-monitoring-in-enhancing-surgical-outcomes-for-patients-with-diabetes-8920https://curecurrent.com/trials/xinqiao-high-risk-cohort-of-diabetes-nice-8921https://curecurrent.com/trials/investigation-of-the-effects-of-different-exercise-on-wound-healing-in-patients-w-th-diabetic-foot-wounds-8922https://curecurrent.com/trials/voice-activated-and-touchscreen-controlled-smart-speaker-intervention-for-older-adults-with-poorly-controlled-type-2-dia-8923https://curecurrent.com/trials/inflammation-and-diabetes-evaluating-antioxidant-levels-8924https://curecurrent.com/trials/evaluation-of-neuregulin-4-nrg4-levels-in-obese-and-non-obese-patients-with-type-2-diabetes-mellitus-8925https://curecurrent.com/trials/ai-assisted-remote-insulin-pump-optimization-in-t1dm-8926https://curecurrent.com/trials/hybrid-closed-loop-insulin-delivery-after-pancreatectomy-8927https://curecurrent.com/trials/is-serum-irisin-level-a-biomarker-in-diabetic-polyneuropathy-8928https://curecurrent.com/trials/phase-i-study-to-evaluate-the-pharmacokinetics-and-safety-after-co-administration-of-l03rd1-and-l03rd2-or-administration-8929https://curecurrent.com/trials/zirconia-reinforced-glass-ionomer-versus-injectable-giomer-in-class-v-restorations-8930https://curecurrent.com/trials/bone-marrow-adipose-tissue-in-relation-to-bone-and-energy-metabolism-in-obesity-and-type-2-diabetes-mellitus-8931https://curecurrent.com/trials/an-observational-study-to-learn-more-about-how-safe-finerenone-is-and-how-well-it-works-in-indian-people-with-chronic-ki-8932https://curecurrent.com/trials/aim-met-ai-guided-microbiome-targeted-nutrition-for-glycemic-improvement-in-type-2-diabetes-8933https://curecurrent.com/trials/observation-of-iris-blood-flow-via-octa-in-diabetic-neovascular-glaucoma-8934https://curecurrent.com/trials/mhealth-intervention-to-increase-physical-activity-in-prediabetes-and-type-2-diabetes-8935https://curecurrent.com/trials/personalized-meal-timing-and-walking-based-on-glucose-patterns-in-adults-with-prediabetes-8936https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetic-interaction-and-the-safety-of-ad-236a-and-ad-236b-8937https://curecurrent.com/trials/evaluating-the-efficacy-of-pulsating-electromagnetic-field-therapy-by-crad-ulcer-x-01-for-diabetic-foot-ulcers-8938https://curecurrent.com/trials/efficacy-of-once-weekly-semaglutide-in-patients-with-type-2-diabetes-a-non-randomized-clinical-trial-8939https://curecurrent.com/trials/a-study-of-the-intervention-of-time-restricted-eating-in-high-risk-populations-of-gdm-8940https://curecurrent.com/trials/point-of-care-capillary-hba1c-testing-for-type-2-diabetes-screening-among-at-risk-individuals-in-rural-dali-china-8941https://curecurrent.com/trials/na-phenylbutyrate-vascular-trial-8942https://curecurrent.com/trials/culturally-adapted-dietary-clinical-trial-in-pr-8943https://curecurrent.com/trials/evaluation-of-a-paraclinical-test-for-the-diagnosis-of-arterial-insufficiency-in-diabetic-patients-with-foot-ulcers-8944https://curecurrent.com/trials/a-real-world-study-to-investigate-cardiovascular-risk-profile-among-newly-diagnosed-type-2-diabetes-mellitus-t2dm-partic-8945https://curecurrent.com/trials/salivary-cortisol-and-hypercortisolism-in-type-2-diabetes-8946https://curecurrent.com/trials/diet-choice-to-promote-type-2-diabetes-remission-8947https://curecurrent.com/trials/vitamin-d-status-and-lipid-profile-in-obese-adults-with-type-2-diabetes-8948https://curecurrent.com/trials/cardiopulmonary-fitness-and-health-related-quality-of-life-in-children-and-adolescents-with-type-1-diabetes-fit-t1d-8949https://curecurrent.com/trials/cold-spray-for-insulin-injection-pain-in-the-emergency-department-8950https://curecurrent.com/trials/advancing-precision-medicine-for-cardiovascular-disease-and-diabetes-in-asian-populations-digital-intervention-cohort-8951https://curecurrent.com/trials/time-restricted-eating-and-staple-food-reduction-combined-with-app-supported-exercise-for-weight-and-glycemic-control-8952https://curecurrent.com/trials/transcutaneous-pulsed-radiofrequency-for-the-treatment-of-diabetic-peripheral-neuropathy-pain-8953https://curecurrent.com/trials/glycoquest-an-ai-adaptive-cgm-integrated-serious-game-for-pediatric-type-1-diabetes-8954https://curecurrent.com/trials/student-pharmacist-non-pharmacological-intervention-on-type-2-diabetes-management-in-older-asian-adult-populations-8955https://curecurrent.com/trials/relation-between-glycemic-control-and-retinal-microvascular-changes-in-diabetic-patients-using-octa-8956https://curecurrent.com/trials/the-effectiveness-of-smoking-cessation-in-prediabetic-smokers-8957https://curecurrent.com/trials/diabetes-management-for-primary-healthcare-centers-8958https://curecurrent.com/trials/the-relationship-between-psychological-well-being-social-support-and-disease-self-management-in-patients-with-diabetic-n-8959https://curecurrent.com/trials/the-ntu-jo-smart-study-8960https://curecurrent.com/trials/effects-of-for-care-model-on-preventive-medicine-8961https://curecurrent.com/trials/evaluation-of-the-impact-of-psychological-profile-on-diabetic-foot-wound-healing-8962https://curecurrent.com/trials/a-research-study-to-investigate-the-efficacy-and-safety-of-hrs9531-tablets-in-participants-with-type-2-diabetes-mellitus-8963https://curecurrent.com/trials/the-effect-of-autonomic-neuropathy-status-on-the-endpoint-events-in-diabetes-patients-with-coronary-heart-disease-and-sl-8964https://curecurrent.com/trials/cgm-assisted-community-management-for-type-2-diabetes-8965https://curecurrent.com/trials/phosphorus-31-spectroscopy-in-phosphate-diabetes-8966https://curecurrent.com/trials/placental-biology-in-health-and-disease-8967https://curecurrent.com/trials/intranasal-insulin-for-postoperative-delirium-in-older-patients-with-t2dm-8968https://curecurrent.com/trials/nephroprotective-effects-of-fig-ficus-carica-l-leaf-supplementation-8969https://curecurrent.com/trials/effectiveness-of-a-self-health-assessment-mobile-application-in-young-to-midlife-adults-in-hong-kong-8970https://curecurrent.com/trials/cardiovascular-kidney-metabolic-syndrome-registry-8971https://curecurrent.com/trials/a-randomised-controlled-trial-of-a-low-energy-diet-for-improving-functional-status-in-heart-failure-with-preserved-eject-8972https://curecurrent.com/trials/the-achills-trial-application-of-cerament-in-heel-infection-for-lower-limb-salvage-8973https://curecurrent.com/trials/open-label-study-to-evaluate-metreleptin-in-children-under-6-years-of-age-with-generalised-lipodystrophy-8974https://curecurrent.com/trials/effectiveness-and-cost-effectiveness-evaluations-of-ai-assisted-diagnostic-software-verisee-for-ophthalmic-disease-scree-8975https://curecurrent.com/trials/intelligent-care-platform-quasi-experimental-trial-8976https://curecurrent.com/trials/artificial-intelligence-aided-screening-for-patients-with-diabetic-retinopathy-and-age-related-macular-degeneration-in-f-8977https://curecurrent.com/trials/cilostazol-and-aspirin-for-cardiovascular-event-prevention-in-patients-with-type-2-diabetes-8978https://curecurrent.com/trials/cgm-guided-patch-pump-vs-basal-bolus-injection-for-steroid-induced-hyperglycemia-in-sudden-sensorineural-hearing-loss-sh-8979https://curecurrent.com/trials/advanced-hybrid-closed-loop-system-ahcl-in-older-patients-with-type-1-diabetes-mellitus-8980https://curecurrent.com/trials/lifestyle-intervention-to-reduce-the-risk-of-sarcopenia-in-adults-with-diabetes-obesity-treated-with-semaglutide-8981https://curecurrent.com/trials/effect-of-melatonin-in-patients-with-diabetic-peripheral-neuropathy-8982https://curecurrent.com/trials/finerenone-for-the-treatment-of-type-2-diabetes-related-kidney-disease-efficacy-observation-and-related-factor-analysis-8983https://curecurrent.com/trials/open-label-study-of-dimethyl-fumarate-in-adults-with-type-1-diabetes-8984https://curecurrent.com/trials/a-randomized-controlled-trial-to-compare-the-glycemic-control-with-or-without-the-connected-solution-of-adult-type-2-dia-8985https://curecurrent.com/trials/frequency-rhythmic-electrical-modulated-stimulation-effect-in-peripheral-neuropathy-patients-severity-of-cases-and-qol-8986https://curecurrent.com/trials/assessment-of-quality-of-life-and-psychological-factors-among-women-diagnosed-with-gestational-diabetes-mellitus-8987https://curecurrent.com/trials/dual-vs-triple-lipid-lowering-therapy-in-type-2-diabetes-mellitus-patients-with-elevated-ldl-cholesterol-8988https://curecurrent.com/trials/nurses-health-study-cardiovascular-component-8989https://curecurrent.com/trials/the-effects-of-intermittent-fasting-on-anthropometric-measurements-and-metabolic-parameters-in-prediabetic-patients-8990https://curecurrent.com/trials/efficacy-and-safety-of-mazdutide-in-patients-with-type-2-diabetes-mellitus-and-moderate-to-severe-nonalcoholic-fatty-liv-8991https://curecurrent.com/trials/extended-release-pregabalin-for-the-treatment-of-neuropathic-pain-in-patients-with-diabetic-peripheral-neuropathy-and-po-8992https://curecurrent.com/trials/effect-of-a-collagen-hydrolysate-on-postprandial-blood-glucose-profile-in-prediabetic-and-healthy-subjects-8993https://curecurrent.com/trials/effects-of-exercise-snacks-on-clinical-and-health-outcomes-8994https://curecurrent.com/trials/a-research-study-of-a-new-medicine-nnc9733-0001-in-healthy-participants-and-participants-with-type-2-diabetes-8995https://curecurrent.com/trials/comparative-effects-of-high-intensity-interval-training-and-continuous-endurance-training-among-prediabetic-patients-8996https://curecurrent.com/trials/hypoglycemia-thresholds-in-type-1-diabetes-8997https://curecurrent.com/trials/think-find-solve-activities-for-insulin-self-management-in-type-1-diabetes-8998https://curecurrent.com/trials/pediatric-artificial-intelligence-for-retinopathy-screening-in-children-with-type-1-diabetes-8999https://curecurrent.com/trials/tirzepatide-s-effects-on-epigenetic-aging-and-metabolic-restoration-in-virally-suppressed-people-with-hiv-9000